<html>
<body>
<H2>
Differential Proteome Analysis of Replicative Senescence in Rat Embryo Fibroblasts<A NAME="RFN3"></A><SUP><A HREF="#FN3">*</A></SUP><A NAME="RFN4"></A><SUP>,<A HREF="#FN4"><B>S</B></A></SUP>
</H2>

<STRONG>
</NOBR><NOBR>Silvia Benvenuti<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP></NOBR>, 
<NOBR>Rainer Cramer<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP></NOBR>, 
<NOBR>Christopher C. Quinn<SUP>&#182;</SUP></NOBR>, 
<NOBR>Jim Bruce<SUP>||</SUP></NOBR>, 
<NOBR>Marketa Zvelebil<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP></NOBR>, 
<NOBR>Steven Corless<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Jacquelyn Bond<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Alice Yang<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP></NOBR>, 
<NOBR>Susan Hockfield<SUP>&#182;</SUP></NOBR>, 
<NOBR>Alma L. Burlingame<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP></NOBR>, 
<NOBR>Michael D. Waterfield<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP></NOBR> and 
<NOBR>Parmjit S. Jat<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP><SUP>,<IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP><SUP>,<A HREF="#COR1">**</A></SUP></NOBR>
</STRONG><P>
<FONT SIZE=-1>
<SUP><IMG SRC="/math/Dagger.gif" ALT="{ddagger}" BORDER="0"></SUP> Ludwig Institute for Cancer Research, Royal Free and University College School of Medicine, Courtauld Building, 91 Riding House Street, London W1W 7BS, United Kingdom<BR>
<SUP><IMG SRC="/math/sect.gif" ALT="&#167;" BORDER="0"></SUP> Department of Biochemistry and Molecular Biology, University College London, Gower Street, London WC1E 6BT, United Kingdom<BR>
<SUP>&#182;</SUP> Section of Neurobiology, Yale University School of Medicine, New Haven, Connecticut 06520-8001<BR>
<SUP>||</SUP> Oxford GlycoSciences, 10 The Quadrant, Abingdon Science Park, Oxfordshire OX14 3YS, United Kingdom
</FONT><P>





<P>
<A NAME="ABS"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
ABSTRACT
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>ABSTRACT</FONT><BR>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS AND DISCUSSION<BR></A>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">SUMMARY<BR></A>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>


Normal somatic cells undergo a finite number of divisions and<SUP> </SUP>then cease dividing whereas cancer cells are able to proliferate<SUP> </SUP>indefinitely. To identify the underlying mechanisms that limit<SUP> </SUP>the mitotic potential, a two-dimensional differential proteome<SUP> </SUP>analysis of replicative senescence in serially passaged rat<SUP> </SUP>embryo fibroblasts was undertaken. Triplicate independent two-dimensional<SUP> </SUP>gels containing over 1200 spots each were run, curated, and<SUP> </SUP>analyzed. This revealed 49 spots whose expression was altered<SUP> </SUP>more than 2-fold. Of these, 42 spots yielded positive protein<SUP> </SUP>identification by mass spectrometry comprising a variety of<SUP> </SUP>cytoskeletal, heat shock, and metabolic proteins, as well as<SUP> </SUP>proteins involved in trafficking, differentiation, and protein<SUP> </SUP>synthesis, turnover, and modification. These included gelsolin,<SUP> </SUP>a candidate tumor suppressor for breast cancer, and <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase<SUP> </SUP>II, a member of the family of glucosidases that includes <I>klotho</I>;<SUP> </SUP>a defect in <I>klotho</I> expression in mice results in a syndrome<SUP> </SUP>that resembles human aging. Changes in expression of TUC-1,<SUP> </SUP>-2, -4, and -4&#223;, members of the TUC family critical<SUP> </SUP>for neuronal differentiation, were also identified. Some of<SUP> </SUP>the identified changes were also shown to occur in two other<SUP> </SUP>models of senescence, premature senescence of REF52 cells and<SUP> </SUP>replicative senescence of mouse embryo fibroblasts. The majority<SUP> </SUP>of these candidate proteins were unrecognized previously in<SUP> </SUP>replicative senescence. They are now implicated in a new role.<SUP> </SUP><P>

<HR NOSHADE SIZE=1 WIDTH="50%" ALIGN="CENTER">


Cancer arises as a consequence of the accumulation of multiple<SUP> </SUP>independent mutations in genes that regulate cell proliferation<SUP> </SUP>and survival (<A HREF="#R1">1</A>). The acquisition of an unlimited proliferative<SUP> </SUP>potential has been proposed to be one of the critical steps<SUP> </SUP>in this process, because normal cells can only undergo a finite<SUP> </SUP>number of divisions when cultured <I>in vitro</I> before undergoing<SUP> </SUP>replicative senescence (<A HREF="#R2">2</A>). Even though replicative senescence<SUP> </SUP>has been studied extensively and can be overcome by immortalizing<SUP> </SUP>genes, the underlying molecular basis is still not understood<SUP> </SUP>fully.<SUP> </SUP><P>

In human somatic cells telomere shortening is a critical component<SUP> </SUP>of the machinery that counts the number of cell divisions and<SUP> </SUP>therefore entry into senescence. It was proposed initially that<SUP> </SUP>reconstitution of telomerase activity resulting in maintenance<SUP> </SUP>of telomeres was sufficient for immortalization of human somatic<SUP> </SUP>cells, but others have found that this is not sufficient and<SUP> </SUP>requires additional activities such as those that can be provided<SUP> </SUP>by the SV40 (<U>s</U>imian <U>v</U>irus <U>40</U>) large T antigen or inactivation<SUP> </SUP>of the pRB/p16 INK4 pathway (<A HREF="#R3">3</A>&#150;<A HREF="#R5">5</A>). Further studies have<SUP> </SUP>now shown that in freshly isolated human mammary fibroblasts<SUP> </SUP>and endothelial cells, reconstituted telomerase activity was<SUP> </SUP>sufficient neither for immortalization nor maintenance of the<SUP> </SUP>immortal state in cell lines that had been immortalized with<SUP> </SUP>a combination of the SV40 T antigen and the catalytic subunit<SUP> </SUP>of telomerase (<A HREF="#R6">6</A>). Inactivation of SV40 T antigen in these cells<SUP> </SUP>resulted in a rapid and irreversible cessation of cell growth<SUP> </SUP>and entry into senescence.<SUP> </SUP><P>

Even though telomere shortening cannot be demonstrated in rodent<SUP> </SUP>cells, they, too, have a finite life span. In contrast to human<SUP> </SUP>cells this can be overcome readily in rodent cells by either<SUP> </SUP>the exogenous introduction of any member of the family of viral<SUP> </SUP>and cellular immortalizing genes, such as SV40 T antigen, or<SUP> </SUP>even by spontaneous mutation. Interestingly like the human cells<SUP> </SUP>immortalized with SV40 T antigen and hTERT, rodent cells expressing<SUP> </SUP>SV40 T antigen proliferate indefinitely and are absolutely dependent<SUP> </SUP>upon its continued expression for maintenance of growth (<A HREF="#R7">7</A>).<SUP> </SUP>Inactivation also results in a rapid and irreversible cessation<SUP> </SUP>of growth and entry into senescence (<A HREF="#R8">8</A>). Moreover, we have shown<SUP> </SUP>that primary mouse embryo fibroblasts are able to measure their<SUP> </SUP>proliferative life span even in the presence of SV40 T antigen<SUP> </SUP>at the normal rate (<A HREF="#R9">9</A>). Taken together these results have raised<SUP> </SUP>the possibility that the non-telomere shortening-dependent regulatory<SUP> </SUP>components of the finite proliferative life span may be conserved<SUP> </SUP>between human and rodent cells and that human cells may have<SUP> </SUP>acquired telomere shortening as a further control mechanism.<SUP> </SUP><P>

Replicative senescence is an asynchronous process whereby a<SUP> </SUP>growing culture gives rise to an irreversibly arrested culture.<SUP> </SUP>The model systems that are commonly used for its study involve<SUP> </SUP>the isolation and serial <I>in vitro</I> cultivation of primary fibroblasts.<SUP> </SUP>Initially these cells proliferate exponentially but cease dividing<SUP> </SUP>after some passages, at which point the cell numbers no longer<SUP> </SUP>increase. The loss of proliferative potential in such heterogeneous<SUP> </SUP>cultures of primary cells is asynchronous. When these cells<SUP> </SUP>have reached the end of their <I>in vitro</I> mitotic lifespan, they<SUP> </SUP>can be maintained and remain metabolically active but cannot<SUP> </SUP>be induced to undergo new rounds of cell division (<A HREF="#R10">10</A>). In such<SUP> </SUP>model systems, the culture as a whole divides initially and<SUP> </SUP>undergoes growth arrest toward the end; however there can be<SUP> </SUP>growth-arrested cells in the early passages and dividing cells<SUP> </SUP>toward the later passages.<SUP> </SUP><P>

The senescent phenotype is dominant as fusions of senescent<SUP> </SUP>cells with dividing cells give rise to senescent cells (<A HREF="#R11">11</A>).<SUP> </SUP>Even though a variety of traditional approaches have been utilized<SUP> </SUP>to try to identify the underlying changes that are the cause<SUP> </SUP>of senescence, this process is still not understood fully, probably<SUP> </SUP>because these procedures were insufficient to analyze comprehensively<SUP> </SUP>such a complex process. New approaches to address complex biological<SUP> </SUP>systems include DNA microarrays that monitor global changes<SUP> </SUP>in mRNA expression (<A HREF="#R12">12</A>). However studies in <I>Saccharomyces cerevisiae</I><SUP> </SUP>and human liver have suggested that mRNA levels may correlate<SUP> </SUP>poorly with corresponding protein levels (<A HREF="#R13">13</A>, <A HREF="#R14">14</A>), and mRNA-based<SUP> </SUP>assays are unable to detect changes in protein level because<SUP> </SUP>of stability and changes in post-translational modifications.<SUP> </SUP>Another approach would be to analyze changes in protein expression<SUP> </SUP>that have the potential for resolution of all expressed proteins<SUP> </SUP>in a cell (proteome), which can then be identified by mass spectrometry.<SUP> </SUP><P>

Even though not all proteins may be resolved by two-dimensional<SUP> </SUP>(2-D) <A NAME="RFN1"></A><SUP><A HREF="#FN1">1</A></SUP> gels and also may not be identified by mass spectrometry,<SUP> </SUP>we have initiated a differential proteomic approach to study<SUP> </SUP>replicative senescence. This was done, because it has the potential<SUP> </SUP>for identifying changes in protein expression, post-translational<SUP> </SUP>modification, stability, and even changes in cellular localization.<SUP> </SUP>Furthermore, we have chosen to study the protein expression<SUP> </SUP>profiles of serially passaged rat embryo fibroblasts (REFs),<SUP> </SUP>rather than primary human fibroblasts, to minimize differences<SUP> </SUP>because of epigenetic variation between cells obtained from<SUP> </SUP>different donors and also, because human fibroblasts have much<SUP> </SUP>longer finite proliferative lifespan <I>in vitro</I>. Human fibroblasts<SUP> </SUP>are capable of undergoing 50&#150;60 divisions before undergoing<SUP> </SUP>replicative senescence, in contrast to 20&#150;30 divisions<SUP> </SUP>for rodent embryo fibroblasts. The issue of epigenetic variation<SUP> </SUP>was critical, because we needed to be able to go back and repeat<SUP> </SUP>the passaging with freshly isolated identical cells to prepare<SUP> </SUP>protein extracts for validation of the proteome analysis and<SUP> </SUP>also extraction of RNA for determining whether changes at the<SUP> </SUP>protein level correlate with changes at the RNA level. Cells<SUP> </SUP>that are cultivated serially after freezing exhibit an altered<SUP> </SUP>finite mitotic life span.<SUP> </SUP><P>

Changes in protein profiles upon cellular senescence were monitored<SUP> </SUP>by high resolution 2-D polyacrylamide gel electrophoresis, and<SUP> </SUP>differentially expressed protein spots were identified by matrix-assisted<SUP> </SUP>laser desorption/ionization mass spectrometry (MALDI-MS) and<SUP> </SUP>nano-HPLC electrospray ionization tandem mass spectrometry (ESI-MS/MS).<SUP> </SUP>This analysis identified 49 spots whose expression changed more<SUP> </SUP>than 2-fold upon replicative senescence; 32 of these spots were<SUP> </SUP>up-regulated, 12 were down-regulated, and five displayed an<SUP> </SUP>altered migration pattern. The majority of these proteins were<SUP> </SUP>unrecognized previously in replicative senescence. They are<SUP> </SUP>now implicated in a new role.<SUP> </SUP><P>

<A NAME="SEC1"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
EXPERIMENTAL PROCEDURES
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>EXPERIMENTAL PROCEDURES</FONT><BR>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">RESULTS AND DISCUSSION<BR></A>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">SUMMARY<BR></A>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<STRONG><EM>Cell Cultures&#151;</EM></STRONG><BR>

REFs were prepared from 12&#150;13-day-old Sprague-Dawley rat<SUP> </SUP>embryos, cultured, and passaged serially. All cultures were<SUP> </SUP>maintained in Dulbecco&#146;s modified Eagle&#146;s medium<SUP> </SUP>supplemented with 10% (v/v) fetal calf serum, 2 m<FONT SIZE=-2>M</FONT> glutamine,<SUP> </SUP>100 units/ml penicillin, and 100 &#181;g/ml streptomycin. REF52<SUP> </SUP>cells obtained from Scott Lowe were propagated in Dulbecco&#146;s<SUP> </SUP>modified Eagle&#146;s medium supplemented with 10% (v/v) fetal<SUP> </SUP>calf serum, 2 m<FONT SIZE=-2>M</FONT> glutamine, 100 units/ml penicillin, and 100<SUP> </SUP>&#181;g/ml streptomycin. All media and components were obtained<SUP> </SUP>from Invitrogen.<SUP> </SUP><P>

<STRONG><EM>2-D Polyacrylamide Gel Electrophoresis&#151;</EM></STRONG><BR>

2-D gels were prepared and run as described previously (<A HREF="#R15">15</A>).<SUP> </SUP>Staining, scanning, and curation of primary images with subsequent<SUP> </SUP>analysis to identify differential spots were all carried out<SUP> </SUP>by previously published procedures (<A HREF="#R15">15</A>).<SUP> </SUP><P>

<STRONG><EM>Protein Identification by Mass Spectrometry&#151;</EM></STRONG><BR>

Identifications of all differentially expressed proteins utilized<SUP> </SUP>a standard approach using MALDI-MS and if necessary ESI-MS/MS.<SUP> </SUP>Differential spots were excised from one of the triplicate gels,<SUP> </SUP>which showed the highest expression level for each spot. Prior<SUP> </SUP>to mass spectrometry, tryptic in-gel digests were carried out<SUP> </SUP>on all samples using a protocol similar to already published<SUP> </SUP>procedures (<I>e.g.</I> donatello.ucsf.edu/ingel.html; see Ref. <A HREF="#R16">16</A>).<SUP> </SUP>Details of the procedures for peptide mass mapping by matrix-assisted<SUP> </SUP>laser desorption/ionization mass spectrometry and peptide sequencing<SUP> </SUP>by nano-HPLC electrospray ionization tandem mass spectrometry<SUP> </SUP>are provided as Supplementary Material.<SUP> </SUP><P>

<STRONG><EM>1-D Western Blotting&#151;</EM></STRONG><BR>

Cell lysates for immunoblotting were prepared in RIPA buffer<SUP> </SUP>(150 m<FONT SIZE=-2>M</FONT> NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%<SUP> </SUP>SDS, 50 m<FONT SIZE=-2>M</FONT> Tris-HCl, pH 8.0). Protein concentrations were determined<SUP> </SUP>using the Bradford reagent (Bio-Rad). 30 &#181;g of each protein<SUP> </SUP>lysate was fractionated on an SDS polyacrylamide gel, transferred<SUP> </SUP>to Hybond C membrane, and probed with the following antibodies:<SUP> </SUP><IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase (StressGene), HSP27 Ab-1 (NeoMarkers), HSP70 W27<SUP> </SUP>(Santa Cruz Biotechnology), CDC47 (NeoMarkers), gelsolin (kindly<SUP> </SUP>provided by Helen Yin), cyclin A Ab-4 (Oncogene Science), and<SUP> </SUP>p19<SUP>ARF</SUP> (Abcam).<SUP> </SUP><P>

<STRONG><EM>Semiquantititative RT-PCR Analysis&#151;</EM></STRONG><BR>

First strand cDNA was prepared from 2 &#181;g of total RNA<SUP> </SUP>using SuperScript<SUP>TM</SUP> II Moloney murine leukemia virus RNaseH<SUP>-</SUP><SUP> </SUP>reverse transcriptase from Invitrogen according to the manufacturer&#146;s<SUP> </SUP>instructions. RNA was denatured (65&#176;C for 5 min) in the<SUP> </SUP>presence of an oligo(dT) primer (0.5 &#181;g; Promega) and<SUP> </SUP>dNTPs (0.5 m<FONT SIZE=-2>M</FONT>; Promega) and quickly chilled on ice. Ribonuclease<SUP> </SUP>inhibitor (RNasin; Promega) and dithiothreitol (100 m<FONT SIZE=-2>M</FONT>) were<SUP> </SUP>then added, together with 1<FONT FACE="arial,helvetica">x</FONT> first strand buffer, and incubated<SUP> </SUP>at 42&#176;C for 2 min. Moloney murine leukemia virus RNaseH<SUP>-</SUP><SUP> </SUP>reverse transcriptase (200 units) was added, and reactions were<SUP> </SUP>incubated at 42&#176;C for 50 min, followed by heat inactivation<SUP> </SUP>at 70&#176;C for 15 min.<SUP> </SUP><P>

For each gene, an optimal cycle number was established that<SUP> </SUP>enabled the bands to be visible on a gel but did not result<SUP> </SUP>in saturation of the amplification procedure. This was done<SUP> </SUP>partially by confirming that the same relative intensities were<SUP> </SUP>obtained when the cycle number was increased by two cycles.<SUP> </SUP>The sequences of the primers used for PCRs, along with the product<SUP> </SUP>size, cycle numbers, and annealing temperatures, are provided<SUP> </SUP>as Supplementary Material. All PCR reactions were carried out<SUP> </SUP>in 50 &#181;l and contained 1 &#181;l of first strand cDNA.<SUP> </SUP>They also contained 0.5 &#181;g of each oligonucleotide primer,<SUP> </SUP>2.5 units of <I>Thermus aquaticus</I> (<I>Taq</I>) DNA polymerase (Promega),<SUP> </SUP>1<FONT FACE="arial,helvetica">x</FONT> PCR buffer (10 m<FONT SIZE=-2>M</FONT> Tris-HCl, pH 9, 50 m<FONT SIZE=-2>M</FONT> KCl, 0.1% (w/v) Triton<SUP> </SUP>X-100 (10<FONT FACE="arial,helvetica">x</FONT> PCR buffer provided by Promega)), 0.5 m<FONT SIZE=-2>M</FONT> dNTPs (Promega),<SUP> </SUP>and 1.5&#150;2.5 m<FONT SIZE=-2>M</FONT> MgCl<SUB>2</SUB> (Promega). The optimum MgCl<SUB>2</SUB> concentration<SUP> </SUP>was determined for each primer set and is also provided as Supplementary<SUP> </SUP>Material.<SUP> </SUP><P>

A 5-min 95&#176;C denaturation step was used prior to amplification.<SUP> </SUP>The amplification parameters were denaturation at 94&#176;C for<SUP> </SUP>1 min, annealing at the specific temperature for each primer<SUP> </SUP>pair for 1 min, and extension at 72&#176;C for 1 min, with a<SUP> </SUP>final extension of 5 min at 72&#176;C after the last cycle. For<SUP> </SUP>each PCR, appropriate controls were carried out to check for<SUP> </SUP>nonspecific amplification. All PCR primers were designed using<SUP> </SUP>Primer3 software (<A HREF="http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi">www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi</A>).<SUP> </SUP><P>

<STRONG><EM>Premature Senescence of REF52 Cells&#151;</EM></STRONG><BR>

BOSC23 cells (1.75 <FONT FACE="arial,helvetica">x</FONT> 10<SUP>6</SUP>) were plated in a 6-cm dish and transfected<SUP> </SUP>24 h later with 3 &#181;g of either pBabePuroEJras or pBabePuro<SUP> </SUP>using FuGENE (Roche Molecular Biochemicals). 48 h after transfection,<SUP> </SUP>the virus-containing medium was removed, filtered (though a<SUP> </SUP>0.45 &#181;<FONT SIZE=-2>M</FONT> filter), and used to infect REF52 cells in the<SUP> </SUP>presence of 8 &#181;g/ml polybrene (Aldrich). REF52 were plated<SUP> </SUP>at 8 <FONT FACE="arial,helvetica">x</FONT> 10<SUP>5</SUP> cells per 10-cm dish and incubated overnight prior<SUP> </SUP>to infection. For the infection, the culture medium was replaced<SUP> </SUP>by 2 ml of virus-containing medium for 2 h. The infection was<SUP> </SUP>repeated a second time 6 h later. Sixteen h later, the infected<SUP> </SUP>cultures were subjected to 2 &#181;g/ml puromycin selection.<SUP> </SUP>The medium was changed on the third day, and the infected cells<SUP> </SUP>were extracted with RIPA buffer after 7 days.<SUP> </SUP><P>

<A NAME="SEC2"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
RESULTS AND DISCUSSION
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>RESULTS AND DISCUSSION</FONT><BR>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">SUMMARY<BR></A>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<STRONG><EM>2-D Gel Analysis</EM></STRONG><BR>

REFs were prepared from 12&#150;13-day-old Sprague-Dawley rat<SUP> </SUP>embryos and passaged using the 3T3 passaging regime of Todaro<SUP> </SUP>and Green (<A HREF="#R17">17</A>). Cells were passaged serially until they ceased<SUP> </SUP>to divide and cell numbers no longer increased, which takes<SUP> </SUP>about five passages. Cultures were continually examined microscopically<SUP> </SUP>to ensure that there were no mitotic cells visible when passaging<SUP> </SUP>was ceased. This involved plating 2.6 <FONT FACE="arial,helvetica">x</FONT> 10<SUP>6</SUP> cells per 15-cm<SUP> </SUP>dish. Cells were plated on day 0 and allowed to adhere, the<SUP> </SUP>medium was changed on day 1, and the cells passaged on day 3.<SUP> </SUP>For preparation of cell lysates, cells were harvested on day<SUP> </SUP>2. In this way all lysates were prepared from cultures that<SUP> </SUP>were in fresh medium and subconfluent and thus not quiescent.<SUP> </SUP>This was done to ensure that only changes in expression because<SUP> </SUP>of senescence were being examined.<SUP> </SUP><P>

Triplicate independent total protein extracts prepared from<SUP> </SUP>three serially passaged independent dishes of REFs at P2 (proliferating<SUP> </SUP>cells), P3, P4, and P5 (senescent cells) were fractionated on<SUP> </SUP>2-D gels to visualize changes in the proteome. The fractionated<SUP> </SUP>proteins were detected by staining the gels with the fluorescent<SUP> </SUP>dye OGT MP17, followed by scanning at a detection level of less<SUP> </SUP>than 1 ng of protein. A representative 2-D gel for P2 and P5<SUP> </SUP>senescent REFs is shown in <A HREF="#F1">Fig. 1</A>. The triplicate scanned gels<SUP> </SUP>were then subjected to triplicate curation in which the gel<SUP> </SUP>with the most spots (detected using MELANIE II software) was<SUP> </SUP>chosen as the reference gel, and the two other gels were called<SUP> </SUP>gel II and III, respectively. First gel II was curated against<SUP> </SUP>the reference gel and then gel III was curated against it. Next<SUP> </SUP>gel II was curated against gel III. Although triplicate curation<SUP> </SUP>is a time-consuming procedure, it allows identification of differential<SUP> </SUP>features using only the reference gels. However it is necessary<SUP> </SUP>as a follow-up to check manually that all features expressed<SUP> </SUP>differentially in the reference gel are also differential in<SUP> </SUP>the other two gels within the triplicate. Only protein spots<SUP> </SUP>that changed more than 2-fold in magnitude, in the same direction<SUP> </SUP>(<I>i.e.</I> up or down), and were observed in all three gels were<SUP> </SUP>considered. The pI and molecular weight of each spot was calculated<SUP> </SUP>by bilinear interpolation between landmark spots on each image<SUP> </SUP>that had been calibrated previously with respect to <I>Escherichia<SUP> </SUP>coli</I> proteins. After curation, each gel was found to comprise<SUP> </SUP>over 1200 spots. Moreover, the gels were very reproducible among<SUP> </SUP>each triplicate (the % of homology among the gels was always<SUP> </SUP>above 90%, shown in <A HREF="#T1">Table I</A>).<SUP> </SUP><P>

<A NAME="F1"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/280/F1"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=106 HEIGHT=200 SRC="/content/vol1/issue4/images/small/jw0420037001.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (92K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/F1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/F1"
    onClick="startTarget('F1', 384, 640); this.href='/cgi/content-nw/full/1/4/280/F1'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 1. <B>A representative 2-D gel image of P2 and P5 cells obtained upon fractionation of 150 &#181; g of total cell extract.</B><P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="T1"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/T1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/T1"
    onClick="startTarget('T1', 500, 400); this.href='/cgi/content-nw/full/1/4/280/T1'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
T<FONT SIZE=-2>ABLE</FONT> I Percent homology between the triplicate gels<P>

Triplicate 2-D gels were run, curated, and compared.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


The detected spots were then submitted to CHIMAP to identify<SUP> </SUP>the differentials. CHIMAP is a newly developed program that<SUP> </SUP>calculates a differential value between a large series of matched<SUP> </SUP>features either as a percentage change or a -fold change and<SUP> </SUP>represents them graphically (<A HREF="#R18">18</A>). It generally uses the Ward&#146;s<SUP> </SUP>minimum variance method although other agglomeration methods<SUP> </SUP>can be selected within the program. The comparison of growing<SUP> </SUP><I>versus</I> senescent REFs identified 49 spots that were reproducibly<SUP> </SUP>regulated differentially, of which 32 were up-regulated, 12<SUP> </SUP>were down-regulated, and five shifted in their position of migration<SUP> </SUP>(shown in <A HREF="#T2">Table II</A>). Representative features that correspond<SUP> </SUP>to each type of differential are shown in <A HREF="#F2">Fig. 2</A>. We also examined<SUP> </SUP>expression of the differential spots, in P3 and P4 gels, to<SUP> </SUP>determine whether the changes were also observed at these passages<SUP> </SUP>and whether they occurred stepwise or processively (shown in<SUP> </SUP>Supplemental Material, <A HREF="#T1">Table I</A>).<SUP> </SUP><P>

<A NAME="T2"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/T2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/T2"
    onClick="startTarget('T2', 500, 400); this.href='/cgi/content-nw/full/1/4/280/T2'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
T<FONT SIZE=-2>ABLE</FONT> II Protein annotations<P>

ID, identity number; F.C., -fold change; h, human; m, mouse; r, rat; c, chicken; b, bovine. *, only contaminants such as human keratin were identified.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="F2"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/280/F2"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=121 HEIGHT=200 SRC="/content/vol1/issue4/images/small/jw0420037002.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (39K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/F2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/F2"
    onClick="startTarget('F2', 416, 640); this.href='/cgi/content-nw/full/1/4/280/F2'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 2. <B>2-D gel images showing selected up-regulated features (<I>panel A</I>), down-regulated features (<I>panel B</I>), and a feature with an altered migration (<I>panel C</I>).</B><P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<STRONG><EM>Protein Identification by Mass Spectrometry</EM></STRONG><BR>

<FONT SIZE=-1><STRONG>Peptide Mass Mapping by MALDI-MS&#151;</STRONG></FONT><BR>

Analysis of the differentially regulated spots by MALDI-MS yielded<SUP> </SUP>24 single positive identifications, two double positive identifications,<SUP> </SUP>six single putative identifications, one double putative identification,<SUP> </SUP>and one double mixed (positive and putative) identification<SUP> </SUP>(shown in <A HREF="#T2">Table II</A>, and presented in greater detail as Supplemental<SUP> </SUP>Material, <A HREF="#T2">Table II</A>). Five spots yielded only keratin, and in<SUP> </SUP>four cases, more than 20 peptide ion signals were obtained,<SUP> </SUP>but database searches with these peptide mass lists did not<SUP> </SUP>identify any proteins. For the remaining six of the 49 differential<SUP> </SUP>spots, the mass spectra recorded exhibited not more than 10<SUP> </SUP>peptides; these data were classified as insufficient for peptide<SUP> </SUP>mass mapping. From all identified proteins only 18 proteins<SUP> </SUP>were identified as rat proteins, nine were mouse, nine were<SUP> </SUP>human, and one was bovine. Interestingly, five proteins identified<SUP> </SUP>as non-rat proteins have rat homologues in the NCBI protein<SUP> </SUP>database suggesting either extensive nucleotide polymorphisms<SUP> </SUP>or incorrect database entries for the rat protein sequences.<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Protein Identification by ESI-MS/MS&#151;</STRONG></FONT><BR>

ESI-MS/MS analysis was performed in all cases where peptide<SUP> </SUP>mass mapping by MALDI-MS was unsuccessful or ambiguous. In addition,<SUP> </SUP>a few spots with sufficient MALDI-MS data for protein identification<SUP> </SUP>were analyzed by ESI-MS/MS to verify the identification by MALDI-MS<SUP> </SUP>peptide mass mapping. Almost two-thirds of the excised spots<SUP> </SUP>were analyzed by nano-HPLC ESI-MS/MS. The results for the protein<SUP> </SUP>identification by ESI-MS/MS (false positives excluded) are also<SUP> </SUP>summarized in <A HREF="#T2">Table II</A> and presented in greater detail as Supplemental<SUP> </SUP>Material, Tables III and IV. From all proteins identified by<SUP> </SUP>searching the NCBI protein database only 15 proteins were identified<SUP> </SUP>as rat proteins, whereas three were from mouse, one was from<SUP> </SUP>chicken, one was from Chinese hamster, and 10 were human. MS/MS<SUP> </SUP>data from two spots identified human proteins with some peptides<SUP> </SUP>giving matches to the mouse and bovine homologues that did not<SUP> </SUP>match the human protein. Similarly, MS/MS data from one other<SUP> </SUP>spot resulted in peptide matches not matching the rat protein<SUP> </SUP>but rather the Chinese hamster homologue. The chicken myosin<SUP> </SUP>heavy chain identified in spot 190 was quite unusual, because<SUP> </SUP>a very close rat homologue exists in the NCBI protein database.<SUP> </SUP>However, the peptides for which the MS/MS data were obtained<SUP> </SUP>cover regions with little homology suggesting that the rat homologue<SUP> </SUP>remains to be identified.<SUP> </SUP><P>

Positive protein identifications obtained by MALDI-MS peptide<SUP> </SUP>mass mapping were confirmed in all cases where ESI-MS/MS was<SUP> </SUP>employed. All putatively identified proteins by MALDI-MS peptide<SUP> </SUP>mass mapping were also confirmed by ESI-MS/MS whenever sufficient<SUP> </SUP>data were obtained. In addition to these confirmations three<SUP> </SUP>more proteins were identified, t-complex polypeptide in sample<SUP> </SUP>497, lamin A or C2 in sample 504, and heat shock protein 27<SUP> </SUP>in sample 1295. For five previously unidentified spots, positive<SUP> </SUP>protein identification was obtained. The comparison of the results<SUP> </SUP>from the MALDI-MS and ESI-MS/MS data demonstrated that both<SUP> </SUP>techniques show comparable sensitivity in protein identification.<SUP> </SUP>Furthermore, this comparison also showed that the criteria applied<SUP> </SUP>for protein identification were reliable and gave virtually<SUP> </SUP>no false identifications, with a minimal loss in analytical<SUP> </SUP>sensitivity.<SUP> </SUP><P>

<STRONG><EM>Description of Differentially Expressed Proteins</EM></STRONG><BR>

The differentially expressed proteins comprised a variety of<SUP> </SUP>cytoskeletal, heat shock, and metabolic proteins, as well as<SUP> </SUP>proteins involved in trafficking, differentiation, and protein<SUP> </SUP>synthesis, turnover, and modification. For the purposes of the<SUP> </SUP>discussion below, we have assumed that all proteins identified<SUP> </SUP>by mass spectrometry for each spot were expressed differentially.<SUP> </SUP>However this may clearly not be the case for spots that yielded<SUP> </SUP>multiple proteins; for these spots Western blot analysis using<SUP> </SUP>specific antibodies will be required to determine the identity<SUP> </SUP>of the differential protein.<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Cytoskeletal Proteins&#151;</STRONG></FONT><BR>

A number of the proteins identified, like gelsolin, &#223;-tubulin,<SUP> </SUP>and Arp2 (<U>a</U>ctin-<U>r</U>elated <U>p</U>rotein <U>2</U>), have been shown previously<SUP> </SUP>to be involved in cytoskeletal scaffolding. Most of these proteins<SUP> </SUP>were up-regulated during senescence; however &#223;-tubulin<SUP> </SUP>was down-regulated. It is perhaps not surprising that proteins<SUP> </SUP>involved in the cytoskeleton show changes in expression upon<SUP> </SUP>replicative senescence, because senescent cells are very different<SUP> </SUP>morphologically from growing cells; they have the classic fried<SUP> </SUP>egg morphology of senescent cells. They are much larger, have<SUP> </SUP>lots of stress fibers, and overexpress many extracellular matrix<SUP> </SUP>components such as collagenases, collagen, stromolysin, and<SUP> </SUP>fibronectin.<SUP> </SUP><P>

Gelsolin is involved in nucleation of actin filaments and is<SUP> </SUP>responsible for regulating the growth rate of these filaments<SUP> </SUP>and therefore has a role in cell motility (<A HREF="#R19">19</A>). It mediates<SUP> </SUP>the rapid remodeling of cortical actin filaments and has a role<SUP> </SUP>in stress fiber-dependent cell function (<A HREF="#R20">20</A>). Gelsolin is also<SUP> </SUP>a caspase 3 substrate and is cleaved during Fas-mediated apoptosis<SUP> </SUP>(<A HREF="#R21">21</A>) and gives rise to a fragment that can depolymerize actin<SUP> </SUP>filaments and either promote or inhibit apoptosis depending<SUP> </SUP>on the cell type (<A HREF="#R22">22</A>).<SUP> </SUP><P>

Here we have found that gelsolin (spot 190) was up-regulated<SUP> </SUP>4.8-fold upon replicative senescence; growing cells have low<SUP> </SUP>levels of gelsolin whereas post-mitotic senescent cells have<SUP> </SUP>high levels of gelsolin. This was consistent with previous observations<SUP> </SUP>that gelsolin was down-regulated in several types of transformed<SUP> </SUP>cells and tumors (<A HREF="#R23">23</A>&#150;<A HREF="#R25">25</A>). The partial or total loss of<SUP> </SUP>gelsolin expression in a majority of breast cancers of diverse<SUP> </SUP>aetiologies has led to the proposal that gelsolin is a candidate<SUP> </SUP>tumor suppressor gene for breast cancer (<A HREF="#R26">26</A>). Both gelsolin<SUP> </SUP>protein and its mRNA have been shown to be down-regulated in<SUP> </SUP>cancer cells, suggesting that an alteration in the rate of transcription<SUP> </SUP>underlies the dysfunction of this gene (<A HREF="#R26">26</A>). The decrease at<SUP> </SUP>the transcriptional level is most likely to be because of loss<SUP> </SUP>of p53, because it has been found recently that gelsolin is<SUP> </SUP>up-regulated transcriptionally by p53 (<A HREF="#R27">27</A>).<SUP> </SUP><P>

Moesin, radixin, and ezrin, members of the ERM family of proteins,<SUP> </SUP>are general cross-linkers between cortical actin filaments and<SUP> </SUP>plasma membranes. They are involved in the formation of microvilli,<SUP> </SUP>cell adhesion sites, cleavage furrows, and membrane ruffling<SUP> </SUP>(<A HREF="#R28">28</A>). It is interesting to note that moesin was identified as<SUP> </SUP>an up-regulated (spot 331), as well as a down-regulated (spot<SUP> </SUP>332) protein, and thus represents a feature that shifts in its<SUP> </SUP>migration. Because these spots migrate at the same molecular<SUP> </SUP>weight but different pI, it suggests that it is not the level<SUP> </SUP>of the protein that changes but rather the modification. Because<SUP> </SUP>the feature that is up-regulated has a higher pI, it suggests<SUP> </SUP>that moesin is most likely undergoing phosphorylation upon senescence.<SUP> </SUP><P>

Spot 902 that was up-regulated 2-fold in senescent REFs was<SUP> </SUP>found to comprise Arp2 and hnRNP-E2. The Arp2/3 protein is ubiquitous<SUP> </SUP>and an essential component of the actin cytoskeleton in eukaryotic<SUP> </SUP>cells. It nucleates actin filaments, caps their pointed ends,<SUP> </SUP>and cross-links them into orthogonal networks (<A HREF="#R29">29</A>, <A HREF="#R30">30</A>). Arp2/3<SUP> </SUP>proteins are activated by the GTPase Cdc42, together with the<SUP> </SUP>WASP family of proteins (<A HREF="#R31">31</A>). They are expressed differentially<SUP> </SUP>between human breast myoepithelial and luminal epithelial cells<SUP> </SUP>(<A HREF="#R15">15</A>).<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Heat Shock Proteins&#151;</STRONG></FONT><BR>

Four HSPs were identified during this study. HSP105 (spot 110),<SUP> </SUP>HSP90<IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0"> (spot 185), and HSP27 (spot 1302) were up-regulated, and<SUP> </SUP>HSP70, identified in spot 153, together with Sec23 and ischemia-responsive<SUP> </SUP>94-kDa protein, was down-regulated. HSPs are a group of proteins<SUP> </SUP>that are highly conserved from bacteria to mammals and classified<SUP> </SUP>into different families according to their size as follows:<SUP> </SUP>HSP110/105, 90, 70, 60, 40, and 27. They were identified initially<SUP> </SUP>by virtue of their rapid induction under stress conditions and<SUP> </SUP>proposed to play a critical role in protection from hypothermia<SUP> </SUP>and other types of stress (<A HREF="#R32">32</A>&#150;<A HREF="#R34">34</A>). However they are now<SUP> </SUP>known to play essential roles under normal physiological conditions<SUP> </SUP>such as assisting the folding of newly synthesized proteins,<SUP> </SUP>protein translocation across organelle membranes, promoting<SUP> </SUP>assembly or disassembly of oligomeric proteins, and facilitating<SUP> </SUP>protein degradation of incorrectly folded or denatured proteins.<SUP> </SUP>They have also been shown to localize to the centrosome, but<SUP> </SUP>the significance of this localization is not clear (<A HREF="#R35">35</A>). The<SUP> </SUP>mammalian HSP110/105 may exist as two forms, <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0"> and &#223;.<SUP> </SUP>Even though both forms are induced upon stress, the <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0"> form is<SUP> </SUP>also expressed constitutively (<A HREF="#R36">36</A>). Both forms associate with<SUP> </SUP>HSP70 and have been proposed to regulate negatively its chaperone<SUP> </SUP>activity. They are also induced upon adipocyte differentiation<SUP> </SUP>(<A HREF="#R37">37</A>). Our finding that HSP27 was up-regulated upon senescence<SUP> </SUP>is in accordance with the observation that overexpression of<SUP> </SUP>HSP27 in bovine pulmonary endothelial cells stimulates their<SUP> </SUP>growth rate and accelerates the rate at which the cultures reach<SUP> </SUP>senescence (<A HREF="#R38">38</A>). HSP27 is also expressed differentially between<SUP> </SUP>human breast luminal and myoepithelial cells (<A HREF="#R15">15</A>).<SUP> </SUP><P>

The finding that heat shock proteins were expressed differentially<SUP> </SUP>may be particularly relevant, because it has been proposed by<SUP> </SUP>some that replicative senescence in rodent cells may be caused<SUP> </SUP>by the stress of <I>in vitro</I> tissue culture (<A HREF="#R62">62</A>, <A HREF="#R63">63</A>). It is has<SUP> </SUP>been observed that increased stress such as freeze-thawing and<SUP> </SUP>growth at lower temperatures can shorten the finite proliferative<SUP> </SUP>life span (<A HREF="#R9">9</A>). Increases in resistance to stress have been shown<SUP> </SUP>to increase chronological lifespan in <I>Drosophila melanogaster</I><SUP> </SUP>and <I>Caenorhabditis elegans</I> by acting on post-mitotic cells rather<SUP> </SUP>than affecting replicative potential (<A HREF="#R64">64</A>). Stress resistance<SUP> </SUP>could be increased by reducing expression of HSP90, which can<SUP> </SUP>down-regulate heat shock transcription factor HS1 (<A HREF="#R64">64</A>). Induction<SUP> </SUP>of HSP70, the most abundant and most evolutionarily conserved,<SUP> </SUP>by stress is significantly lower in late passage senescent fibroblasts,<SUP> </SUP>probably because of reduced levels of HSF1 that are required<SUP> </SUP>for transcriptional up-regulation of HSP70 (<A HREF="#R65">65</A>). Recently two<SUP> </SUP>mortalin genes (Mot1 and Mot2), members of the HSP70 family<SUP> </SUP>that are derived from two distinct genes, were identified. They<SUP> </SUP>encode proteins that differ by only two amino acids but exhibit<SUP> </SUP>different subcellular localizations and have contrasting activities.<SUP> </SUP>Mot1 induces senescence in NIH 3T3 cells whereas Mot2 results<SUP> </SUP>in transformation. Mot2 has also been shown to increase proliferative<SUP> </SUP>life span and block induction of senescence-associated-&#223;-galactosidase<SUP> </SUP>activity in normal human diploid fibroblasts by interfering<SUP> </SUP>with p53 activity by blocking nuclear translocation of p53 and<SUP> </SUP>down-regulating p53-responsive genes (<A HREF="#R66">66</A>, <A HREF="#R67">67</A>). Because up-regulation<SUP> </SUP>of HSP90 could account for down-regulation of HSP70 via HSF1,<SUP> </SUP>it suggests that it would be very important to determine what<SUP> </SUP>is the cause of the up-regulation of HSP90 and if it is because<SUP> </SUP>of stress of <I>in vitro</I> tissue culture, to determine the nature<SUP> </SUP>of this stress. It will also be interesting to determine whether<SUP> </SUP>HSP105/110 and 27 are also up-regulated by the same mechanism.<SUP> </SUP>One possible mechanism would be via a common transcription factor.<SUP> </SUP>It is also important to determine the exact form of HSP70 that<SUP> </SUP>we have found to be down-regulated and whether it corresponds<SUP> </SUP>to one of the mortalin proteins, particularly Mot2.<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Factors Affecting Protein Synthesis&#151;</STRONG></FONT><BR>

Two proteins, ERF1 (<U>e</U>ukaryotic <U>r</U>eleasing <U>f</U>actor <U>1</U>, spot 677)<SUP> </SUP>and elongation factor-1-<IMG SRC="/math/ggr.gif" ALT="{gamma}" BORDER="0"> (spot 773), that may play a role in<SUP> </SUP>protein synthesis, were up-regulated upon senescence. ERF has<SUP> </SUP>been implicated in translation termination in eukaryotes (<A HREF="#R39">39</A>).<SUP> </SUP>Although its function in translation termination remains obscure,<SUP> </SUP>it has been shown to promote a stop codon and ribosome-dependent<SUP> </SUP>hydrolysis of aminoacyl-tRNAs (<A HREF="#R40">40</A>) and thus catalyzes the termination<SUP> </SUP>of protein synthesis at all three stop codons. It has been conserved<SUP> </SUP>remarkably during evolution suggesting that it may have an essential<SUP> </SUP>role in the termination of translation (<A HREF="#R41">41</A>). Elongation factor-1-<IMG SRC="/math/ggr.gif" ALT="{gamma}" BORDER="0">,<SUP> </SUP>a subunit of EF1, one of the G-proteins that mediate transport<SUP> </SUP>of aminoacyl-tRNA to the 80 S ribosomes during translation,<SUP> </SUP>has been found to be overexpressed in colorectal carcinomas<SUP> </SUP>and adenomas (<A HREF="#R42">42</A>, <A HREF="#R43">43</A>). Therefore it was rather surprising that<SUP> </SUP>we found elongation factor-1-<IMG SRC="/math/ggr.gif" ALT="{gamma}" BORDER="0"> be up-regulated upon replicative<SUP> </SUP>senescence.<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Proteins Involved in Differentiation&#151;</STRONG></FONT><BR>

Two differentially regulated spots were identified as proteins<SUP> </SUP>belonging to the TUC (TOAD-64/<U>U</U>lip/<U>C</U>RMP) family of intracellular<SUP> </SUP>phosphoproteins implicated in axon guidance and outgrowth and<SUP> </SUP>thereby regulation of neuronal differentiation (<A HREF="#R44">44</A>&#150;<A HREF="#R46">46</A>).<SUP> </SUP>The TUC family consists of four 64-kDa isoforms known as TUC-1<SUP> </SUP>(CRMP-1/Ulip-3), TUC-2 (CRMP-2/Ulip-2), TUC-3 (CRMP-3/Ulip4),<SUP> </SUP>and TUC-4 (CRMP-4/Ulip-1). In addition, TUC-4&#223; has<SUP> </SUP>been identified recently as a 75-kDa variant of TUC-4. <A NAME="RFN2"></A><SUP><A HREF="#FN2">2</A></SUP> The<SUP> </SUP>TUC proteins are up-regulated in the rat brain after embryonic<SUP> </SUP>day 12, a time that corresponds to the beginning of neurogenesis.<SUP> </SUP>TUC-4 is the most abundant member of this family and first detected<SUP> </SUP>in new post-mitotic neurons after neuronal birth (<A HREF="#R47">47</A>), reaches<SUP> </SUP>peak expression levels during neurogenesis but is not expressed<SUP> </SUP>by neural progenitor cells. It is down-regulated in the adult<SUP> </SUP>brain but is re-expressed if axonal re-growth is triggered.<SUP> </SUP>It is also increased upon differentiation of PC12 cells by nerve<SUP> </SUP>growth factor and neuroblastoma cells by retinoic acid. In contrast<SUP> </SUP>to TUC-4, much less is known about the expression of the other<SUP> </SUP>TUC proteins. TUC-2 is expressed by both neurons and their progenitors.<SUP> </SUP>It is also slightly up-regulated upon treatment of PC12 cells<SUP> </SUP>with nerve growth factor. Recently TUC-2 was found to be associated<SUP> </SUP>with the microtubule bundles at the mitotic spindle and proposed<SUP> </SUP>to be involved in regulating microtubule dynamics (<A HREF="#R48">48</A>). The<SUP> </SUP>TUC proteins are also required for the growth cone collapsing<SUP> </SUP>activity of semaphorin-3A, an extracellular guidance cue for<SUP> </SUP>axonal outgrowth, suggesting a role in the signal transduction<SUP> </SUP>pathway initiated by extracellular stimuli. Their importance<SUP> </SUP>in neuronal differentiation is further suggested by their homology<SUP> </SUP>to <I>unc-33</I>, a <I>C. elegans</I> gene that is required for normal axon<SUP> </SUP>outgrowth and guidance. They are also highly conserved across<SUP> </SUP>species; the rat TUC-2 protein has 98% identity with its chicken<SUP> </SUP>ortholog and 89% identity with its <I>Xenopus laevis</I> ortholog.<SUP> </SUP>The proteins identified by the proteomic analysis correspond<SUP> </SUP>to TUC-2 in spot 304 and TUC-4 in spot 495 that also contained<SUP> </SUP>the <IMG SRC="/math/ggr.gif" ALT="{gamma}" BORDER="0">-subunit of the TCP-1 chaperone (<A HREF="#R45">45</A>). TUC-2 was down-regulated<SUP> </SUP>2.4-fold whereas TUC-4 was up-regulated when REFs underwent<SUP> </SUP>senescence, in accordance with the idea that TUC-4 is an early<SUP> </SUP>marker of post-mitotic neurons. Interestingly TUC-2 showed an<SUP> </SUP>opposite regulation to TUC-4; it was down-regulated in the post-mitotic<SUP> </SUP>senescent cells.<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Protein Turnover, Synthesis, and Modification&#151;</STRONG></FONT><BR>

Some differential spots were identified as subunits of the proteasome<SUP> </SUP>complex, the 26 S proteasome subunit p40.5 and RC10-II. The<SUP> </SUP>level of subunit p40.5 (spot 907) increases upon senescence<SUP> </SUP>whereas RC10-II both decreases in level (spot 1239) and shifts<SUP> </SUP>in its migration (spot 1348). The shift in migration is most<SUP> </SUP>likely to be because of changes in post-translational modification<SUP> </SUP>such as phosphorylation. The p40.5 subunit is expressed differentially<SUP> </SUP>between human luminal and myoepithelial cells (<A HREF="#R15">15</A>). In contrast,<SUP> </SUP>changes in the migration pattern of the RC10-II have not been<SUP> </SUP>observed previously. It would therefore be very interesting<SUP> </SUP>to determine the site of phosphorylation, the kinase responsible,<SUP> </SUP>and how it is regulated.<SUP> </SUP><P>

Other proteins that could potentially be considered to be members<SUP> </SUP>of this family of differentially expressed proteins are <I>O</I>-GlcNAc<SUP> </SUP>transferase p110 subunit (spot 108), seryl-tRNA synthetase (spot<SUP> </SUP>497), alanyl-tRNA synthetase (spot 102), and an ATP-dependent<SUP> </SUP>RNA helicase p47 (spot 677). All these proteins were identified<SUP> </SUP>as up-regulated proteins. <I>O</I>-GlcNAc transferase is capable of<SUP> </SUP>glycosylating both serine and threonine residues on nuclear<SUP> </SUP>and cytosolic proteins. On several proteins the <I>O</I>-GlcNAc and<SUP> </SUP><I>O</I>-phosphorylation occur on the same or adjacent sites, and thus<SUP> </SUP>it is possible that one function of the addition of <I>O</I>-GlcNAc<SUP> </SUP>is to block phosphorylation at this site (<A HREF="#R49">49</A>). Therefore the<SUP> </SUP><I>O</I>-GlcNAc modification may have an important role in control<SUP> </SUP>of intracellular signaling. It is highly conserved, dynamic,<SUP> </SUP>and inducible. Disruption of <I>O</I>-GlcNAc transferase in mouse embryonic<SUP> </SUP>stem cells is lethal, demonstrating the importance of this modification.<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Protein Trafficking&#151;</STRONG></FONT><BR>

SEC23 identified in the down-regulated spot 153 in senescent<SUP> </SUP>cells has been proposed to be involved in protein trafficking.<SUP> </SUP>It is a component of COPII, a cytosolic complex that is responsible<SUP> </SUP>for the formation of vesicles within the endoplasmic reticulum<SUP> </SUP>and involved in the anterograde transport of proteins to the<SUP> </SUP>Golgi (<A HREF="#R50">50</A>, <A HREF="#R51">51</A>). In contrast to SEC23, transferrin (spot 290)<SUP> </SUP>and RA410, a vesicle transport-related protein (spot 426), both<SUP> </SUP>appear to be up-regulated upon senescence. None of these proteins<SUP> </SUP>have been found previously to be expressed differentially in<SUP> </SUP>senescence or tumorigenesis. Nevertheless, RA410 has been proposed<SUP> </SUP>to have a role in post-Golgi transport and participates in the<SUP> </SUP>ischemia-related stress response in astrocytes (<A HREF="#R52">52</A>).<SUP> </SUP><P>

<FONT SIZE=-1><STRONG>Metabolic Proteins&#151;</STRONG></FONT><BR>

Two up-regulated spots (spots 122 and 127) that were identified<SUP> </SUP>to be the <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-subunit of the <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase II complex were particularly<SUP> </SUP>interesting. <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-Glucosidase II is the soluble form of the enzyme<SUP> </SUP>and removes the <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-1,2-glucose and <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-1,3-glucose residues following<SUP> </SUP>transfer of Glc<SUB>3</SUB>Man<SUB>9</SUB>GlcNAc<SUB>2</SUB> to nascent polypeptides (<A HREF="#R53">53</A>). The<SUP> </SUP><IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidases participate in glycoprotein folding mediated by<SUP> </SUP>calnexin and calreticulin by forming the monoglucosylated high<SUP> </SUP>mannose oligosaccharides required for interaction with chaperones.<SUP> </SUP>In addition to their role in <I>N</I>-glycan processing, these enzymes<SUP> </SUP>are involved intimately in quality control in the endoplasmic<SUP> </SUP>reticulum, a process that ensures proper folding of newly formed<SUP> </SUP>polypeptide chains leading to retention and/or degradation of<SUP> </SUP>incorrectly folded proteins (<A HREF="#R53">53</A>). Interestingly it was shown<SUP> </SUP>recently that a 3'-untranslated region of an <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase-related<SUP> </SUP>mRNA was able to promote colony formation and immortalization<SUP> </SUP>in REFs and cooperate with an immortalization-defective mutant<SUP> </SUP>of SV40 T antigen to immortalize REFs (<A HREF="#R54">54</A>). Moreover, a gene<SUP> </SUP>named <I>klotho</I> (<A HREF="#R55">55</A>) that shares sequence homology to the &#223;-glucosidase<SUP> </SUP>family of enzymes and encodes a secreted protein that appears<SUP> </SUP>to function outside cells has been identified recently. A defect<SUP> </SUP>in its expression in mice results in a syndrome that resembles<SUP> </SUP>human aging (short lifespan, infertility, arteriosclerosis,<SUP> </SUP>skin atrophy, osteoporosis, and emphysema) (<A HREF="#R55">55</A>).<SUP> </SUP><P>

We also identified other differentially expressed metabolic<SUP> </SUP>proteins. Among these, 2-oxoglutarate dehydrogenase precursor<SUP> </SUP>(spot 104), 2-oxoglutarate dioxygenase <IMG SRC="/math/ggr.gif" ALT="{gamma}" BORDER="0">-butyrobetaine (spot<SUP> </SUP>493), and isopentenyl diphosphate dimethylallyl diphosphate<SUP> </SUP>isomerase (spot 1075) were up-regulated whereas GDP dissociation<SUP> </SUP>inhibitor of the Rho protein (spot 1054) was down-regulated.<SUP> </SUP>PRx IV (spot 1295), an enzyme with antioxidant function, was<SUP> </SUP>down-regulated whereas PRx III was found both to be down-regulated<SUP> </SUP>(spot 1239) and to undergo changes in mobility (spot 1351).<SUP> </SUP>Guanosine 5'-monophosphate synthetase (spot 332) was identified<SUP> </SUP>in a down-regulated spot.<SUP> </SUP><P>

<STRONG><EM>Validation of the 2-D Proteome Analysis</EM></STRONG><BR>

To validate the 2-D proteome analysis, REFs were passaged serially<SUP> </SUP>again using the strict 3T3 passaging regime to prepare extracts<SUP> </SUP>corresponding to P2, P3, P4, and P5 and analyzed for expression<SUP> </SUP>by 1-D Western blotting. To ensure that the extracts exhibited<SUP> </SUP>changes in expression of proteins known to be involved in replicative<SUP> </SUP>senescence, extracts were first analyzed for expression of cyclin<SUP> </SUP>A and p19<SUP>ARF</SUP>. As expected cyclin A was down-regulated, and p19<SUP>ARF</SUP><SUP> </SUP>was up-regulated as REFs underwent replicative senescence (<A HREF="#F3">Fig.<SUP> </SUP>3<I>A</I></A>). Expression was then analyzed for some of the identified<SUP> </SUP>proteins for which antibodies were available.<SUP> </SUP><P>

<A NAME="F3"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/280/F3"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=113 HEIGHT=200 SRC="/content/vol1/issue4/images/small/jw0420037003.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (36K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/F3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/F3"
    onClick="startTarget('F3', 399, 640); this.href='/cgi/content-nw/full/1/4/280/F3'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 3. <B>A</B>, 1-D Western blots using 30 &#181;g of total protein per sample. <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-Glucosidase, gelsolin, TUC-4, and TUC-2 show correlation between 2-D and 1-D gels. No correlation was found for HSP27. Cyclin A and p19<SUP>ARF</SUP>, known to be modulated upon replicative senescence, were used as a positive control; &#223; actin was used to control for equal loading. <I>B</I>, RT-PCR analysis of differentially expressed candidate genes. A direct correlation between protein and mRNA levels was found for TUC-2 but not for <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase, TUC-4, and gelsolin. p21<SUP>WAF1/Sdi1/CIP1</SUP>, a gene known to be up-regulated upon replicative senescence, was used as a positive control; &#223; actin was used as control.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


Expression analysis of gelsolin, <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase, and TUC-4 showed<SUP> </SUP>that they were up-regulated whereas TUC-2 was down-regulated<SUP> </SUP>in accordance with the proteome analysis (<A HREF="#F3">Fig. 3<I>A</I></A>). In contrast,<SUP> </SUP>even though HSP27 had been identified as an up-regulated feature,<SUP> </SUP>it was not found to be differential by 1-D Western blot analysis<SUP> </SUP>(see <A HREF="#F2">Fig. 2<I>A</I></A> and <A HREF="#F3">Fig. 3<I>A</I></A>). The most likely explanation for this<SUP> </SUP>is that HSP27 may have multiple isoforms and therefore be present<SUP> </SUP>as multiple spots on the 2-D gels, and only one of these spots<SUP> </SUP>was differential. Thus the identity of the form of HSP27 that<SUP> </SUP>is expressed differentially upon replicative senescence remains<SUP> </SUP>to be determined. The 1-D Western blot experiments were repeated<SUP> </SUP>several times, and as expected each single experiment gave the<SUP> </SUP>same result. Further blotting experiments using specific antisera<SUP> </SUP>against the remainder of identified proteins are required to<SUP> </SUP>validate fully the differential proteome analysis.<SUP> </SUP><P>

We next undertook experiments to determine whether the changes<SUP> </SUP>at the protein level that were validated by 1-D Western blotting<SUP> </SUP>correlated with changes in mRNA by semiquantitative RT-PCR;<SUP> </SUP>the results are presented in <A HREF="#F3">Fig. 3<I>B</I></A>. Once again REFs were passaged<SUP> </SUP>serially using the strict 3T3 passaging regime and RNA extracted<SUP> </SUP>from cultures of P2, P3, P4, and P5 REFs. For these experiments<SUP> </SUP>p21<SUP>WAF1/Sdi1/CIP1</SUP>, known to be up-regulated upon replicative<SUP> </SUP>senescence (<A HREF="#R56">56</A>), was used as a positive control. TUC-2 RNA decreased<SUP> </SUP>in accordance with the decrease in protein level. The level<SUP> </SUP>of TUC-4 and <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase RNA did not change whereas gelsolin<SUP> </SUP>RNA showed a slight increase. These results are consistent with<SUP> </SUP>the studies in <I>S. cerevisiae</I> and human liver, which have suggested<SUP> </SUP>that mRNA levels may correlate poorly with corresponding protein<SUP> </SUP>levels (<A HREF="#R13">13</A>, <A HREF="#R14">14</A>).<SUP> </SUP><P>

Because TUC-4 and TUC-2 are two members of the same family of<SUP> </SUP>proteins but showed opposite regulation at the protein level,<SUP> </SUP>we analyzed expression of other members of this family. The<SUP> </SUP>results presented in <A HREF="#F4">Fig. 4<I>A</I></A> show that TUC-4&#223;, a variant<SUP> </SUP>of TUC-4, was up-regulated, and TUC-1 was down-regulated, whereas<SUP> </SUP>TUC-3 was not present in the REFs. TUC-4&#223; has been<SUP> </SUP>found previously to only be expressed in neural cells and cell<SUP> </SUP>lines of neural origin such as PC12, N1E-115, and neuro-2a cells.<SUP> </SUP>Interestingly both TUC-4 and TUC-4&#223; were detected<SUP> </SUP>in all three of these cell lines, as well as in brain and REF<SUP> </SUP>extracts. The significance of the changes in expression of this<SUP> </SUP>family of proteins is not yet understood. Neither is it clear<SUP> </SUP>what is their function and whether they have overlapping functions.<SUP> </SUP>Nevertheless it is highly intriguing that the different family<SUP> </SUP>members show divergent but identical regulation in both neural<SUP> </SUP>differentiation and in fibroblasts upon replicative senescence.<SUP> </SUP><P>

<A NAME="F4"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/280/F4"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=80 HEIGHT=200 SRC="/content/vol1/issue4/images/small/jw0420037004.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (31K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/F4">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/F4"
    onClick="startTarget('F4', 327, 640); this.href='/cgi/content-nw/full/1/4/280/F4'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F4">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 4. <B>A</B>, protein expression of the TUC family of proteins was analyzed using specific antisera. An E18 rat brain extract was used as a positive control. <I>B</I>, protein expression in the REF model of the replicative senescence model was compared with the premature senescence model (<A HREF="#R49">49</A>) in which REF52 are induced to undergo senescence upon ectopic expression of activated Ras. Cyclin A and p19<SUP>ARF</SUP>, known to be expressed differentially in both model systems, were used as a positive control. A direct correlation between the two models was found for <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase, gelsolin, and TUC-2. <I>C</I>, 20 &#181;g of total cell lysates per sample were treated with Lambda protein phosphatase (BioLabs) prior to Western blotting.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


We next examined whether some of the changes observed in replicative<SUP> </SUP>senescence also occur in oncogene-induced premature senescence,<SUP> </SUP>another commonly used system for studying senescence. In this<SUP> </SUP>model, REF52 cells, from an immortal rat cell line, are induced<SUP> </SUP>to senescence prematurely by ectopic expression of the activated<SUP> </SUP>Ha-Ras oncogene (<A HREF="#R57">57</A>). The results in <A HREF="#F4">Fig. 4<I>B</I></A> show that as observed<SUP> </SUP>previously, cyclin A was down-regulated whereas p19<SUP>ARF</SUP> was up-regulated<SUP> </SUP>upon premature senescence. In accordance with replicative senescence,<SUP> </SUP>both <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase and gelsolin were up-regulated whereas TUC-2<SUP> </SUP>was down-regulated upon premature senescence. In addition to<SUP> </SUP>the major TUC-2 band, minor bands that migrated more slowly<SUP> </SUP>were detected in P2 REFs and growing REF52 cells whereas they<SUP> </SUP>were absent in senescent REFs or prematurely senescent REF52<SUP> </SUP>cells, but a more prominent faster migrating band was observed.<SUP> </SUP>Phosphatase treatment of extracts before Western blotting indicated<SUP> </SUP>that at least one of the slower migrating bands observed in<SUP> </SUP>the dividing REFs, as well as REF52 cells, but not in the growth-arrested<SUP> </SUP>cells was due to phosphorylation (<A HREF="#F4">Fig. 4<I>C</I></A>). TUC-4&#223;<SUP> </SUP>splice variant was not detected in REF52 cells, and rather surprisingly<SUP> </SUP>TUC-4 showed the opposite regulation upon premature senescence.<SUP> </SUP>These experiments have been repeated several times, and each<SUP> </SUP>experiment yielded the same result. Gelsolin and <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase<SUP> </SUP>were also found to be up-regulated when mouse embryo fibroblasts<SUP> </SUP>were passaged serially <I>in vitro</I>, and cultures ceased dividing<SUP> </SUP>and underwent replicative senescence (<A HREF="#F5">Fig. 5</A>). Unfortunately<SUP> </SUP>these were the only two candidates for which the antibodies<SUP> </SUP>were capable of detecting the mouse protein. As more mouse specific<SUP> </SUP>antibodies become available it will be very interesting to validate<SUP> </SUP>the differential proteome analysis in the mouse system.<SUP> </SUP><P>

<A NAME="F5"><!-- null --></A>
<BR CLEAR=all><CENTER><TABLE WIDTH=95% CELLPADDING=0 
CELLSPACING=0><TR BGCOLOR=e1e1e1><TD><TABLE CELLPADDING=2 CELLSPACING=2>
<TR BGCOLOR=e1e1e1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/1/4/280/F5"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=170 SRC="/content/vol1/issue4/images/small/jw0420037005.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (73K):<BR>
<NOBR><A HREF="/cgi/content/full/1/4/280/F5">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/1/4/280/F5"
    onClick="startTarget('F5', 590, 573); this.href='/cgi/content-nw/full/1/4/280/F5'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F5">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
F<FONT SIZE=-2>IG</FONT>. 5. <B>Protein expression in P2 and P5 REFs was compared with P2 and P8 mouse embryo fibroblasts (<I>MEFs</I>).</B> Cyclin A expression was analyzed as a positive control.<P>


</TD></TR></TABLE>
</TD></TR></TABLE></CENTER>&nbsp;<BR>


<A NAME="SEC3"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
SUMMARY
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">RESULTS AND DISCUSSION<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>SUMMARY</FONT><BR>
<A  HREF="#BIBL"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/darrow.gif">REFERENCES<BR></A>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

Here we have presented a 2-D differential proteome analysis<SUP> </SUP>of replicative senescence in serially passaged rat embryo fibroblasts.<SUP> </SUP>Triplicate independent 2-D gels containing over 1200 spots each<SUP> </SUP>were run, curated, and analyzed. This revealed 49 spots, whose<SUP> </SUP>expression was altered more than 2-fold. Mass spectrometry yielded<SUP> </SUP>positive protein identification for 39 of these spots, comprising<SUP> </SUP>a variety of cytoskeletal, heat shock, and metabolic proteins,<SUP> </SUP>as well as proteins involved in trafficking, differentiation,<SUP> </SUP>and protein synthesis, turnover, and modification. Because proteomic<SUP> </SUP>studies do identify occasionally false positives, we validated<SUP> </SUP>this study by 1-D Western blotting using antisera where available.<SUP> </SUP>We next showed that some of the candidates were also expressed<SUP> </SUP>differentially in two other models of senescence, Ras-induced<SUP> </SUP>premature senescence of REF52 cells and replicative senescence<SUP> </SUP>of mouse embryo fibroblasts.<SUP> </SUP><P>

2-D gels have been used previously to compare the patterns of<SUP> </SUP>protein expression between normal and transformed cell lines.<SUP> </SUP>In studies where 400&#150;1000 proteins were compared, it was<SUP> </SUP>reported that transformation caused a significant change in<SUP> </SUP>expression for 10&#150;30% of the proteins (<A HREF="#R58">58</A>, <A HREF="#R59">59</A>). In addition<SUP> </SUP>a number of marker proteins such as the tropomyosin family of<SUP> </SUP>cytoskeletal proteins and the proliferation sensitive nuclear<SUP> </SUP>antigen for this process were identified (<A HREF="#R58">58</A>, <A HREF="#R60">60</A>). These studies<SUP> </SUP>were extended by Garrels and Franza (<A HREF="#R58">58</A>, <A HREF="#R59">59</A>) to generate a 2-D<SUP> </SUP>gel database for REF52 cells under a variety of growth states<SUP> </SUP>such as quiescence, rapidly dividing, and upon transformation<SUP> </SUP>by DNA and RNA tumor viruses. Moreover for a number of these<SUP> </SUP>2-D spots, they determined the identity, the subcellular localization,<SUP> </SUP>and the post-translational modifications. Replicative senescence<SUP> </SUP>has not been analyzed previously by 2-D gels, and our study<SUP> </SUP>is one of the first such studies. In contrast to transformation,<SUP> </SUP>where 10&#150;30% of the spots were differential, we found<SUP> </SUP>that only 49 spots of <IMG SRC="/math/sim.gif" ALT="~" BORDER="0">1200 were altered more than 2-fold (<IMG SRC="/math/sim.gif" ALT="~" BORDER="0">4%).<SUP> </SUP>Because we have used triplicate curation to maximize reproducibility<SUP> </SUP>and eliminate false positives, it is possible that 4% differentials<SUP> </SUP>might be a slight underestimate for the proportion of differential<SUP> </SUP>spots, but it is considerably lower than the 10&#150;30% differentials<SUP> </SUP>found in the REF52 studies. None of the differential spots that<SUP> </SUP>we have identified correspond to those identified previously<SUP> </SUP>by Garrels and Franza (<A HREF="#R58">58</A>). This is perhaps not surprising,<SUP> </SUP>because REF52 cells are an immortal rat cell line, and the aim<SUP> </SUP>of our experiments was to identify changes that are the cause<SUP> </SUP>of the senescent phenotype, and these changes should not occur<SUP> </SUP>in REF52 cells when the immortal state is unaffected such as<SUP> </SUP>in quiescence, rapid cell division, and transformation.<SUP> </SUP><P>

Even though the proteins that we have identified have not been<SUP> </SUP>directly associated with replicative senescence previously,<SUP> </SUP>some of them, for example gelsolin, <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase, TUC, and heat<SUP> </SUP>shock proteins, have been linked to cell proliferation. Gelsolin<SUP> </SUP>has been proposed to be a tumor suppressor for breast cancer.<SUP> </SUP>A 3'-untranslated region of an <IMG SRC="/math/agr.gif" ALT="{alpha}" BORDER="0">-glucosidase-related mRNA has<SUP> </SUP>been shown to be able to promote colony formation and immortalization<SUP> </SUP>in REFs and cooperate with an immortalization-defective mutant<SUP> </SUP>of SV40 T antigen to immortalize REFs (<A HREF="#R54">54</A>). The TUC proteins<SUP> </SUP>are critical for neuronal differentiation, and it has been proposed<SUP> </SUP>by some that replicative senescence reflects a state of terminal<SUP> </SUP>differentiation (<A HREF="#R61">61</A>) and that senescent fibroblasts are the<SUP> </SUP>equivalent of terminally differentiated end stage cells. However,<SUP> </SUP>the mechanisms by which these proteins modulate cell growth<SUP> </SUP>are unknown.<SUP> </SUP><P>

The finding that TUC genes are expressed differentially upon<SUP> </SUP>replicative senescence suggests another family of proteins that<SUP> </SUP>may be involved in this process. Treatment of neuroblastoma<SUP> </SUP>cells with retinoic acid results in differential expression<SUP> </SUP>of the same TUC genes that we have observed. This treatment<SUP> </SUP>also affects expression of the p73 family of proteins, and p73<SUP> </SUP>knock-out mice have a neuronal differentiation defect. p73 proteins<SUP> </SUP>are one of the two recently discovered members of the family<SUP> </SUP>of p53 related genes. We have already shown that p63 proteins,<SUP> </SUP>derived from the other member of this p53 family, are expressed<SUP> </SUP>differentially in replicative senescence and proposed that they<SUP> </SUP>may have a role in modulating p53 activity during replicative<SUP> </SUP>senescence (<A HREF="#R68">68</A>). Moreover because the TUC-2 gene is down-regulated<SUP> </SUP>at the level of mRNA, it will be very interesting to determine<SUP> </SUP>whether this occurs at the level of transcription or stability<SUP> </SUP>and to determine the cause.<SUP> </SUP><P>

Therefore further experiments are necessary to determine whether<SUP> </SUP>any of the differentially expressed proteins, either singly<SUP> </SUP>or in combination, have a role in replicative senescence. The<SUP> </SUP>differentially expressed proteins also represent important starting<SUP> </SUP>points for determining the activities critical for the observed<SUP> </SUP>changes in expression whether they occur at the level of mRNA<SUP> </SUP>or protein or by post-translational modification and whether<SUP> </SUP>they are involved in replicative senescence of human cells.<SUP> </SUP>They may provide new markers for cancer diagnosis and therapeutics.<SUP> </SUP><P>

<SUP> </SUP><P>


<A NAME="ACK"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
ACKNOWLEDGMENTS
</FONT></TH></TR></TABLE>
&nbsp;<BR>

We are grateful to Alison Lloyd, Yasuo Ihara, and Helen Yin<SUP> </SUP>for the generous gift of antibodies. We are indebted to all<SUP> </SUP>our colleagues, Roy Katso in particular, for helpful discussions.<SUP> </SUP><P>


<A NAME="FN"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
FOOTNOTES
</FONT></TH></TR></TABLE>
&nbsp;<BR>
Received, October 31, 2001, and in revised form, March 11, 2002.<P>

<A NAME=""><!-- null --></A>
Published, MCP Papers in Press, March 11, 2002, DOI 10.1074/mcp.M100028-MCP200<SUP> </SUP><P>

<A NAME="FN1"><!-- null --></A>
<SUP><SUP>1</SUP></SUP> The abbreviations used are: 2-D, two-dimensional; REF, rat embryo<SUP> </SUP>fibroblast; MALDI-MS, matrix-assisted laser desorption/ionization<SUP> </SUP>mass spectrometry; HPLC, high pressure liquid chromatography;<SUP> </SUP>ESI-MS/MS, electrospray ionization tandem mass spectrometry;<SUP> </SUP>RT, reverse transcriptase; HSP, heat shock protein; 1-D, one-dimensional.<SUP> </SUP><A HREF="#RFN1"><IMG BORDER=0 WIDTH=12 HEIGHT=12 ALT="Back"
SRC="/icons/back.gif"></A><P>
<A NAME="FN2"><!-- null --></A>
<SUP><SUP>2</SUP></SUP> C. C. Q., unpublished observations.<SUP> </SUP><A HREF="#RFN2"><IMG BORDER=0 WIDTH=12 HEIGHT=12 ALT="Back"
SRC="/icons/back.gif"></A><P>
<A NAME="FN3"><!-- null --></A>
<SUP>*</SUP> The costs of publication of this article were defrayed in part<SUP> </SUP>by the payment of page charges. This article must therefore<SUP> </SUP>be hereby marked "advertisement" in accordance with 18 U.S.C.<SUP> </SUP>Section 1734 solely to indicate this fact.<SUP> </SUP><A HREF="#RFN3"><IMG BORDER=0 WIDTH=12 HEIGHT=12 ALT="Back"
SRC="/icons/back.gif"></A><P>
<A NAME="FN4"><!-- null --></A>
<SUP><B>S</B></SUP> The on-line version of this article (available at <A HREF="http://www.mcponline.org">http://www.mcponline.org</A>)<SUP> </SUP>contains Supplemental Material.<SUP> </SUP><A HREF="#RFN4"><IMG BORDER=0 WIDTH=12 HEIGHT=12 ALT="Back"
SRC="/icons/back.gif"></A><P>


<A NAME="COR1"><!-- null --></A>
<SUP>**</SUP> To whom correspondence should be addressed. Tel.: 44-2078784101; Fax: 44-2078784040; E-mail: <span id="em0">parmjit{at}ludwig.ucl.ac.uk</span><script type="text/javascript"><!--
 var u = "parmjit", d = "ludwig.ucl.ac.uk"; document.getElementById("em0").innerHTML = '<a href="mailto:' + u + '@' + d + '">' + u + '@' + d + '<\/a>'//--></script><P>

<A NAME="BIBL"><!-- null --></A>
<BR CLEAR=right><TABLE WIDTH=100% BGCOLOR=e1e1e1 CELLPADDING=0 CELLSPACING=0>
 <TR><TD ALIGN=left VALIGN=middle WIDTH=5% BGCOLOR=ffffff><IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT=" "
SRC="/icons/toc/rarrow.gif"></TD>
 <TH ALIGN=left VALIGN=middle WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;
REFERENCES
</FONT></TH></TR></TABLE>
<TABLE ALIGN=right CELLPADDING=5 BORDER><TR><TH
ALIGN=left><FONT SIZE=-1>
<A HREF="#top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">TOP<BR></A>
<A  HREF="#ABS"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">ABSTRACT<BR></A>
<A  HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES<BR></A>
<A  HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">RESULTS AND DISCUSSION<BR></A>
<A  HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/uarrow.gif">SUMMARY<BR></A>
<IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 ALT=" "
SRC="/icons/toc/dot.gif"><FONT COLOR=464c53>REFERENCES</FONT><BR>
</FONT></TH></TR></TABLE>
&nbsp;<BR>

<OL COMPACT>
<A NAME="R1"><!-- null --></A>
<LI VALUE=1> Hanahan, D., and Weinberg, R. A.
(2000) The hallmarks of cancer.
<I>Cell</I>
<B>100, </B>57
&#150;70<!-- HIGHWIRE ID="1:4:280:1" --><A HREF="/cgi/external_ref?access_num=10647931&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R2"><!-- null --></A>
<LI VALUE=2> Hayflick, L.
(1985) The cell biology of aging.
<I>Clin. Geriatr. Med.</I>
<B>1, </B>15
&#150;27<!-- HIGHWIRE ID="1:4:280:2" --><A HREF="/cgi/external_ref?access_num=3913498&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R3"><!-- null --></A>
<LI VALUE=3> Counter, C. M., Hahn, W. C., Wei, W., Caddle, S. D., Beijersbergen, R. L., Lansdorp, P. M., Sedivy, J. M., and Weinberg, R. A.
(1998) Dissociation among <I>in vitro</I> telomerase activity, telomere maintenance, and cellular immortalization.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>95, </B>14723
&#150;14728<!-- HIGHWIRE ID="1:4:280:3" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=95/25/14723" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R4"><!-- null --></A>
<LI VALUE=4> Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., and Weinberg, R. A.
(1999) Creation of human tumour cells with defined genetic elements.
<I>Nature</I>
<B>400, </B>464
&#150;468<!-- HIGHWIRE ID="1:4:280:4" --><A HREF="/cgi/external_ref?access_num=10.1038/22780&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10440377&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R5"><!-- null --></A>
<LI VALUE=5> Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J.
(1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.
<I>Nature</I>
<B>396, </B>84
&#150;88<!-- HIGHWIRE ID="1:4:280:5" --><A HREF="/cgi/external_ref?access_num=10.1038/23962&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9817205&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R6"><!-- null --></A>
<LI VALUE=6> O&#146;Hare, M. J., Bond, J., Clarke, C., Takeuchi, Y., Atherton, A. J., Berry, C., Moody, J., Silver, A. R., Davies, D. C., Alsop, A. E., Neville, A. M., and Jat, P. S.
(2001) Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>98, </B>646
&#150;651<!-- HIGHWIRE ID="1:4:280:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=98/2/646" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R7"><!-- null --></A>
<LI VALUE=7> Jat, P. S., and Sharp, P. A.
(1989) Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature.
<I>Mol. Cell. Biol.</I>
<B>9, </B>1672
&#150;1681<!-- HIGHWIRE ID="1:4:280:7" --><A HREF="/cgi/external_ref?access_num=2542774&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R8"><!-- null --></A>
<LI VALUE=8> Gonos, E. S., Burns, J. S., Mazars, G. R., Kobrna, A., Riley, T. E., Barnett, S. C., Zafarana, G., Ludwig, R. L., Ikram, Z., Powell, A. J., and Jat, P. S.
(1996) Rat embryo fibroblasts immortalized with simian virus 40 large T antigen undergo senescence upon its inactivation.
<I>Mol. Cell. Biol.</I>
<B>16, </B>5127
&#150;5138<!-- HIGHWIRE ID="1:4:280:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=16/9/5127" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R9"><!-- null --></A>
<LI VALUE=9> Ikram, Z., Norton, T., and Jat, P. S.
(1994) The biological clock that measures the mitotic life-span of mouse embryo fibroblasts continues to function in the presence of simian virus 40 large tumor antigen.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>91, </B>6448
&#150;6452<!-- HIGHWIRE ID="1:4:280:9" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=91/14/6448" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R10"><!-- null --></A>
<LI VALUE=10> Cristofalo, V. J., Phillips, P. D., Sorger, T., and Gerhard, G.
(1989) Alterations in the responsiveness of senescent cells to growth factors.
<I>J. Gerontol.</I>
<B>44, </B>55
&#150;62<!-- HIGHWIRE ID="1:4:280:10" --><A HREF="/cgi/external_ref?access_num=2681364&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R11"><!-- null --></A>
<LI VALUE=11> Pereira-Smith, O. M., Robetorye, S., Ning, Y., and Orson, F. M.
(1990) Hybrids from fusion of normal human T lymphocytes with immortal human cells exhibit limited life span.
<I>J. Cell. Physiol.</I>
<B>144, </B>546
&#150;549<!-- HIGHWIRE ID="1:4:280:11" --><A HREF="/cgi/external_ref?access_num=2391382&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R12"><!-- null --></A>
<LI VALUE=12> Fodor, S. P., Rava, R. P., Huang, X. C., Pease, A. C., Holmes, C. P., and Adams, C. L.
(1993) Multiplexed biochemical assays with biological chips.
<I>Nature</I>
<B>364, </B>555
&#150;556<!-- HIGHWIRE ID="1:4:280:12" --><A HREF="/cgi/external_ref?access_num=10.1038/364555a0&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=7687751&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R13"><!-- null --></A>
<LI VALUE=13> Anderson, L., and Seilhamer, J.
(1997) A comparison of selected mRNA and protein abundances in human liver.
<I>Electrophoresis</I>
<B>18, </B>533
&#150;537<!-- HIGHWIRE ID="1:4:280:13" --><A HREF="/cgi/external_ref?access_num=9150937&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R14"><!-- null --></A>
<LI VALUE=14> Gygi, S. P., Rochon, Y., Franza, B. R., and Aebersold, R.
(1999) Correlation between protein and mRNA abundance in yeast.
<I>Mol. Cell. Biol.</I>
<B>19, </B>1720
&#150;1730<!-- HIGHWIRE ID="1:4:280:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=19/3/1720" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R15"><!-- null --></A>
<LI VALUE=15> Page, M. J., Amess, B., Townsend, R. R., Parekh, R., Herath, A., Brusten, L., Zvelebil, M. J., Stein, R. C., Waterfield, M. D., Davies, S. C., and O&#146;Hare, M. J.
(1999) Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>96, </B>12589
&#150;12594<!-- HIGHWIRE ID="1:4:280:15" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=96/22/12589" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R16"><!-- null --></A>
<LI VALUE=16> Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer, L., Fotsis, T., and Mann, M.
(1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry.
<I>Nature</I>
<B>379, </B>466
&#150;469<!-- HIGHWIRE ID="1:4:280:16" --><A HREF="/cgi/external_ref?access_num=10.1038/379466a0&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8559255&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R17"><!-- null --></A>
<LI VALUE=17> Todaro, G. J., and Green, H.
(1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established cell lines.
<I>J. Cell Biol.</I>
<B>17, </B>299
&#150;313<!-- HIGHWIRE ID="1:4:280:17" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jcb&resid=17/2/299" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R18"><!-- null --></A>
<LI VALUE=18> Harris, R. A., Yang, A., Stein, R. C., Lucy, K., Brusten, L., Herath, A., Parekh, R., Waterfield, M. D., O&#146;Hare, M. J., Neville, M. A., Page, M. J., and Zvelebil, M. J.
(2002) Cluster analysis of an extensive human breast cancer cell line protein expression map database.
<I>Proteomics</I>
<B>2, </B>212
&#150;223<!-- HIGHWIRE ID="1:4:280:18" --><A HREF="/cgi/external_ref?access_num=10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11840567&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R19"><!-- null --></A>
<LI VALUE=19> Kwiatkowski, D. J.
(1999) Functions of gelsolin: motility, signaling, apoptosis, cancer.
<I>Curr. Opin. Cell. Biol.</I>
<B>11, </B>103
&#150;108<!-- HIGHWIRE ID="1:4:280:19" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(99)80012-X&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10047530&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R20"><!-- null --></A>
<LI VALUE=20> Arora, P. D., Janmey, P. A., and McCulloch, C. A.
(1999) A role for gelsolin in stress fiber-dependent cell contraction.
<I>Exp. Cell Res.</I>
<B>250, </B>155
&#150;167<!-- HIGHWIRE ID="1:4:280:20" --><A HREF="/cgi/external_ref?access_num=10.1006/excr.1999.4521&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10388529&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R21"><!-- null --></A>
<LI VALUE=21> Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T. J., Kirschner, M. W., Koths, K., Kwiatkowski, D. J., and Williams, L. T.
(1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis.
<I>Science</I>
<B>278, </B>294
&#150;298<!-- HIGHWIRE ID="1:4:280:21" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=278/5336/294" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R22"><!-- null --></A>
<LI VALUE=22> Kusano, H., Shimizu, S., Koya, R. C., Fujita, H., Kamada, S., Kuzumaki, N., and Tsujimoto, Y.
(2000) Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial changes via closing VDAC.
<I>Oncogene</I>
<B>19, </B>4807
&#150;4814<!-- HIGHWIRE ID="1:4:280:22" --><A HREF="/cgi/external_ref?access_num=10.1038/sj/onc/1203868&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11039896&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R23"><!-- null --></A>
<LI VALUE=23> Vandekerckhove, J., Bauw, G., Vancompernolle, K., Honore, B., and Celis, J.
(1990) Comparative two-dimensional gel analysis and microsequencing identifies gelsolin as one of the most prominent down-regulated markers of transformed human fibroblast and epithelial cells.
<I>J. Cell Biol.</I>
<B>111, </B>95
&#150;102<!-- HIGHWIRE ID="1:4:280:23" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jcb&resid=111/1/95" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R24"><!-- null --></A>
<LI VALUE=24> Lee, H. K., Driscoll, D., Asch, H., Asch, B., and Zhang, P. J.
(1999) Down-regulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate.
<I>Prostate</I>
<B>40, </B>14
&#150;19<!-- HIGHWIRE ID="1:4:280:24" --><A HREF="/cgi/external_ref?access_num=10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10344719&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R25"><!-- null --></A>
<LI VALUE=25> Dong, Y., Asch, H. L., Medina, D., Ip, C., Ip, M., Guzman, R., and Asch, B. B.
(1999) Concurrent deregulation of gelsolin and cyclin D1 in the majority of human and rodent breast cancers.
<I>Int. J. Cancer</I>
<B>81, </B>930
&#150;938<!-- HIGHWIRE ID="1:4:280:25" --><A HREF="/cgi/external_ref?access_num=10.1002/(SICI)1097-0215(19990611)81:6<930::AID-IJC15>3.0.CO;2-A&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10362141&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R26"><!-- null --></A>
<LI VALUE=26> Asch, H. L., Head, K., Dong, Y., Natoli, F., Winston, J. S., Connolly, J. L., and Asch, B. B.
(1996) Widespread loss of gelsolin in breast cancers of humans, mice, and rats.
<I>Cancer Res.</I>
<B>56, </B>4841
&#150;4845<!-- HIGHWIRE ID="1:4:280:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=canres&resid=56/21/4841" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R27"><!-- null --></A>
<LI VALUE=27> Kannan, K., Kaminski, N., Rechavi, G., Jakob-Hirsch, J., Amariglio, N., and Givol, D.
(2001) DNA microarray analysis of genes involved in p53 me-diated apoptosis: activation of Apaf-1.
<I>Oncogene</I>
<B>20, </B>3449
&#150;3455<!-- HIGHWIRE ID="1:4:280:27" --><A HREF="/cgi/external_ref?access_num=10.1038/sj.onc.1204446&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11423996&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R28"><!-- null --></A>
<LI VALUE=28> Tsukita, S., and Yonemura, S.
(1999) Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins.
<I>J. Biol. Chem.</I>
<B>274, </B>34507
&#150;34510<!-- HIGHWIRE ID="1:4:280:28" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=jbc&resid=274/49/34507" ><nobr>[<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R29"><!-- null --></A>
<LI VALUE=29> Mullins, R. D.
(2000) How WASP-family proteins and the Arp2/3 complex convert intracellular signals into cytoskeletal structures.
<I>Curr. Opin. Cell Biol.</I>
<B>12, </B>91
&#150;96<!-- HIGHWIRE ID="1:4:280:29" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(99)00061-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10679362&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R30"><!-- null --></A>
<LI VALUE=30> Mullins, R. D., and Pollard, T. D.
(1999) Structure and function of the Arp2/3 complex.
<I>Curr. Opin. Struct. Biol.</I>
<B>9, </B>244
&#150;249<!-- HIGHWIRE ID="1:4:280:30" --><A HREF="/cgi/external_ref?access_num=10.1016/S0959-440X(99)80034-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10322212&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R31"><!-- null --></A>
<LI VALUE=31> Welch, M. D.
(1999) The world according to Arp: regulation of actin nucleation by the Arp2/3 complex.
<I>Trends Cell Biol.</I>9
: 423
&#150;427<!-- HIGHWIRE ID="1:4:280:31" --><A HREF="/cgi/external_ref?access_num=10.1016/S0962-8924(99)01651-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10511705&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R32"><!-- null --></A>
<LI VALUE=32> Lindquist, S
(1986) The heat-shock response.
<I>Annu. Rev. Biochem.</I>
<B>55, </B>1151
&#150;1191<!-- HIGHWIRE ID="1:4:280:32" --><A HREF="/cgi/external_ref?access_num=10.1146/annurev.biochem.55.1.1151&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=2427013&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R33"><!-- null --></A>
<LI VALUE=33> Hendrick, J. P., and Hartl, F. U.
(1993) Molecular chaperone functions of heat-shock proteins.
<I>Annu. Rev. Biochem.</I>
<B>62, </B>349
&#150;384<!-- HIGHWIRE ID="1:4:280:33" --><A HREF="/cgi/external_ref?access_num=10.1146/annurev.biochem.62.1.349&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=8102520&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R34"><!-- null --></A>
<LI VALUE=34> Verbeke, P., Fonager, J., Clark, B. F., and Rattan, S. I.
(2001) Heat shock response and ageing: mechanisms and applications.
<I>Cell Biol. Int.</I>
<B>25, </B>845
&#150;857<!-- HIGHWIRE ID="1:4:280:34" --><A HREF="/cgi/external_ref?access_num=10.1006/cbir.2001.0789&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11518492&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R35"><!-- null --></A>
<LI VALUE=35> Rattner, J. B.
(1991) hsp70 is localized to the centrosome of dividing HeLa cells.
<I>Exp. Cell Res.</I>
<B>195, </B>110
&#150;113<!-- HIGHWIRE ID="1:4:280:35" --><A HREF="/cgi/external_ref?access_num=2055259&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R36"><!-- null --></A>
<LI VALUE=36> Hatayama, T., Honda, K., and Yukioka, M.
(1986) HeLa cells synthesize a specific heat shock protein upon exposure to heat shock at 42&#176;C but not at 45&#176;C.
<I>Biochem. Biophys. Res. Commun.</I>
<B>137, </B>957
&#150;963<!-- HIGHWIRE ID="1:4:280:36" --><A HREF="/cgi/external_ref?access_num=3729959&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R37"><!-- null --></A>
<LI VALUE=37> Imagawa, M., Tsuchiya, T., and Nishihara, T.
(1999) Identification of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells.
<I>Biochem. Biophys. Res. Commun.</I>
<B>254, </B>299
&#150;305<!-- HIGHWIRE ID="1:4:280:37" --><A HREF="/cgi/external_ref?access_num=10.1006/bbrc.1998.9937&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9918832&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R38"><!-- null --></A>
<LI VALUE=38> Piotrowicz, R. S., Weber, L. A., Hickey, E., and Levin, E. G.
(1995) Accelerated growth and senescence of arterial endothelial cells expressing the small molecular weight heat-shock protein HSP27.
<I>Faseb J.</I>
<B>9, </B>1079
&#150;1084<!-- HIGHWIRE ID="1:4:280:38" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=fasebj&resid=9/11/1079" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R39"><!-- null --></A>
<LI VALUE=39> Frolova, L., Le Goff, X., Rasmussen, H. H., Cheperegin, S., Drugeon, G., Kress, M., Arman, I., Haenni, A. L., Celis, J. E., Philippe, M., Justesen, J., and Kisselev, L.
(1994) A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor.
<I>Nature</I>
<B>372, </B>701
&#150;703<!-- HIGHWIRE ID="1:4:280:39" --><A HREF="/cgi/external_ref?access_num=10.1038/372701a0&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=7990965&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R40"><!-- null --></A>
<LI VALUE=40> Frolova, L. Y., Tsivkovskii, R. Y., Sivolobova, G. F., Oparina, N. Y., Serpinsky, O. I., Blinov, V. M., Tatkov, S. I., and Kisselev, L. L.
(1999) Mutations in the highly conserved GGQ motif of class 1 polypeptide release factors abolish ability of human eRF1 to trigger peptidyl-tRNA hydrolysis.
<I>RNA</I>
<B>5, </B>1014
&#150;1020<!-- HIGHWIRE ID="1:4:280:40" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=rna&resid=5/8/1014" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R41"><!-- null --></A>
<LI VALUE=41> Guenet, L., Toutain, B., Guilleret, I., Chauvel, B., Deaven, L. L., Longmire, J. L., Le Gall, J. Y., David, V., and Le Treut, A.
(1999) Human release factor eRF1: structural organization of the unique functional gene on chromosome 5 and of the three processed pseudogenes.
<I>FEBS Lett.</I>
<B>454, </B>131
&#150;136<!-- HIGHWIRE ID="1:4:280:41" --><A HREF="/cgi/external_ref?access_num=10.1016/S0014-5793(99)00795-4&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10413110&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R42"><!-- null --></A>
<LI VALUE=42> Mimori, K., Mori, M., Inoue, H., Ueo, H., Mafune, K., Akiyoshi, T., and Sugimachi, K.
(1996) Elongation factor 1 gamma mRNA expression in esophageal carcinoma. Gut
<B>38, </B>66
&#150;70<!-- HIGHWIRE ID="1:4:280:42" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=gutjnl&resid=38/1/66" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R43"><!-- null --></A>
<LI VALUE=43> Mimori, K., Mori, M., Tanaka, S., Akiyoshi, T., and Sugimachi, K.
(1995) The overexpression of elongation factor 1 gamma mRNA in gastric carcinoma.
<I>Cancer</I>
<B>75, </B>1446
&#150;1449<!-- HIGHWIRE ID="1:4:280:43" --><A HREF="/cgi/external_ref?access_num=7889472&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R44"><!-- null --></A>
<LI VALUE=44> Byk, T., Ozon, S., and Sobel A
(1998) The Ulip family phosphoproteins&#150;common and specific properties.
<I>Eur. J. Biochem.</I>
<B>254, </B>14
&#150;24<!-- HIGHWIRE ID="1:4:280:44" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=ejbiochem&resid=254/1/14" >[Abstract]</A><!-- /HIGHWIRE --><P><A NAME="R45"><!-- null --></A>
<LI VALUE=45> Wang, L. H., and Strittmatter, S. M.
(1996) A family of rat CRMP genes is differentially expressed in the nervous system.
<I>J. Neurosci.</I>
<B>16, </B>6197
&#150;6207<!-- HIGHWIRE ID="1:4:280:45" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jneuro&resid=16/19/6197" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R46"><!-- null --></A>
<LI VALUE=46> Quinn, C. C., Gray, G. E., and Hockfield, S.
(1999) A family of proteins implicated in axon guidance and outgrowth.
<I>J. Neurobiol.</I>
<B>41, </B>158
&#150;164<!-- HIGHWIRE ID="1:4:280:46" --><A HREF="/cgi/external_ref?access_num=10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10504203&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R47"><!-- null --></A>
<LI VALUE=47> Minturn, J. E., Fryer, H. J., Geschwind, D. H., and Hockfield, S.
(1995) TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a <I>C. elegans</I> gene involved in axon outgrowth.
<I>J. Neurosci.</I>
<B>15, </B>6757
&#150;6766<!-- HIGHWIRE ID="1:4:280:47" --><A HREF="/cgi/external_ref?access_num=7472434&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R48"><!-- null --></A>
<LI VALUE=48> Gu, Y., and Ihara, Y.
(2000) Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules.
<I>J. Biol. Chem.</I>
<B>275, </B>17917
&#150;17920<!-- HIGHWIRE ID="1:4:280:48" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/24/17917" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R49"><!-- null --></A>
<LI VALUE=49> Wells, L., Vosseller, K., and Hart, G. W.
(2001) Glycosylation of nucleocytoplasmic proteins: signal transduction and <I>O</I>-GlcNAc.
<I>Science</I>
<B>291, </B>2376
&#150;2378<!-- HIGHWIRE ID="1:4:280:49" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=291/5512/2376" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R50"><!-- null --></A>
<LI VALUE=50> Barlowe, C.
(1995) COPII: a membrane coat that forms endoplasmic reticulum-derived vesicles.
<I>FEBS Lett.</I>
<B>369, </B>93
&#150;96<!-- HIGHWIRE ID="1:4:280:50" --><A HREF="/cgi/external_ref?access_num=10.1016/0014-5793(95)00618-J&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=7641893&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R51"><!-- null --></A>
<LI VALUE=51> Nickel, W., Brugger, B., and Wieland, F. T.
(1998) Protein and lipid sorting between the endoplasmic reticulum and the Golgi complex.
<I>Semin. Cell Dev. Biol.</I>
<B>9, </B>493
&#150;501<!-- HIGHWIRE ID="1:4:280:51" --><A HREF="/cgi/external_ref?access_num=10.1006/scdb.1998.0256&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9835636&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R52"><!-- null --></A>
<LI VALUE=52> Matsuo, N., Ogawa, S., Takagi, T., Wanaka, A., Mori, T., Matsuyama, T., Pinsky, D. J., Stern, D. M., and Tohyama, M.
(1997) Cloning of a putative vesicle transport-related protein, RA410, from cultured rat astrocytes and its expression in ischemic rat brain.
<I>J. Biol. Chem.</I>
<B>272, </B>16438
&#150;16444<!-- HIGHWIRE ID="1:4:280:52" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=272/26/16438" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R53"><!-- null --></A>
<LI VALUE=53> Herscovics, A.
(1999) Importance of glycosidases in mammalian glycoprotein biosynthesis.
<I>Biochim. Biophys. Acta</I>
<B>1473, </B>96
&#150;107<!-- HIGHWIRE ID="1:4:280:53" --><A HREF="/cgi/external_ref?access_num=10580131&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R54"><!-- null --></A>
<LI VALUE=54> Powell, A. J., Darmon, A. J., Gonos, E. S., Lam, E. W., Peden, K. W., and Jat, P. S.
(1999) Different functions are required for initiation and maintenance of immortalization of rat embryo fibroblasts by SV40 large T antigen.
<I>Oncogene</I>
<B>18, </B>7343
&#150;7350<!-- HIGHWIRE ID="1:4:280:54" --><A HREF="/cgi/external_ref?access_num=10.1038/sj.onc.1203154&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10602490&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R55"><!-- null --></A>
<LI VALUE=55> Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., Iwasaki, H., Iida, A., Shiraki-Iida, T., Nishikawa, S., Nagai, R., and Nabeshima, Y. I.
(1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
<I>Nature</I>
<B>390, </B>45
&#150;51<!-- HIGHWIRE ID="1:4:280:55" --><A HREF="/cgi/external_ref?access_num=10.1038/36285&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9363890&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R56"><!-- null --></A>
<LI VALUE=56> Bringold, F., and Serrano, M.
(2000) Tumor suppressors and oncogenes in cellular senescence.
<I>Exp. Gerontol.</I>
<B>35, </B>317
&#150;329<!-- HIGHWIRE ID="1:4:280:56" --><A HREF="/cgi/external_ref?access_num=10.1016/S0531-5565(00)00083-8&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10832053&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R57"><!-- null --></A>
<LI VALUE=57> Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W.
(1997) Oncogenic Ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
<I>Cell</I>
<B>88, </B>593
&#150;602<!-- HIGHWIRE ID="1:4:280:57" --><A HREF="/cgi/external_ref?access_num=10.1016/S0092-8674(00)81902-9&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9054499&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R58"><!-- null --></A>
<LI VALUE=58> Garrels, J. I., and Franza, B. R., Jr.
(1989) The REF52 protein database. Methods of database construction and analysis using the QUEST system and characterizations of protein patterns from proliferating and quiescent REF52 cells.
<I>J. Biol. Chem.</I>
<B>264, </B>5283
&#150;5298<!-- HIGHWIRE ID="1:4:280:58" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=264/9/5283" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R59"><!-- null --></A>
<LI VALUE=59> Garrels, J. I., and Franza, B. R., Jr.
(1989) Transformation-sensitive and growth-related changes of protein synthesis in REF52 cells. A two-dimensional gel analysis of SV40-, adenovirus-, and Kirsten murine sarcoma virus-transformed rat cells using the REF52 protein database.
<I>J. Biol. Chem.</I>
<B>264, </B>5299
&#150;5312<!-- HIGHWIRE ID="1:4:280:59" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=264/9/5299" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R60"><!-- null --></A>
<LI VALUE=60> Morris, G. F., and Mathews, M. B.
(1989) Regulation of proliferating cell nuclear antigen during the cell cycle.
<I>J. Biol. Chem.</I>
<B>264, </B>13856
&#150;13864<!-- HIGHWIRE ID="1:4:280:60" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=264/23/13856" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R61"><!-- null --></A>
<LI VALUE=61> Bayreuther, K., Rodemann, H. P., Hommel, R., Dittmann, K., Albiez, M., and Francz, P. I.
(1998) Human skin fibroblasts <I>in vitro</I> differentiate along a terminal cell lineage.
<I>Proc. Natl. Acad. Sci. U. S. A.</I>
<B>85, </B>5112
&#150;5116<!-- HIGHWIRE ID="1:4:280:61" --><A HREF="/cgi/external_ref?access_num=10.1073/pnas.95.9.5112&link_type=DOI" >[CrossRef]</A><!-- /HIGHWIRE --><P><A NAME="R62"><!-- null --></A>
<LI VALUE=62> Wright, W. E., and Shay, J. W.
(2000) Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology.
<I>Nat. Med.</I>
<B>6, </B>849
&#150;851<!-- HIGHWIRE ID="1:4:280:62" --><A HREF="/cgi/external_ref?access_num=10.1038/78592&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10932210&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R63"><!-- null --></A>
<LI VALUE=63> Serrano, M., and Blasco, M. A.
(2001) Putting the stress on senescence.
<I>Curr. Opin. Cell Biol.</I>
<B>13, </B>748
&#150;753<!-- HIGHWIRE ID="1:4:280:63" --><A HREF="/cgi/external_ref?access_num=10.1016/S0955-0674(00)00278-7&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11698192&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R64"><!-- null --></A>
<LI VALUE=64> Harris, N., MacLean, M., Hatzianthis, K., Panaretou, B., and Piper, P. W.
(2001) Increasing <I>Saccharomyces cerevisiae</I> stress resistance, through the overactivation of the heat shock response resulting from defects in the Hsp90 chaperone, does not extend replicative life span but can be associated with slower chronological ageing of nondividing cells.
<I>Mol. Genet. Genomics</I>
<B>265, </B>258
&#150;263<!-- HIGHWIRE ID="1:4:280:64" --><A HREF="/cgi/external_ref?access_num=10.1007/s004380000409&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11361336&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R65"><!-- null --></A>
<LI VALUE=65> Gutsmann-Conrad, A., Heydari, A. R., You, S., and Richardson, A.
(1998) The expression of heat shock protein 70 decreases with cellular senescence
<I>in vitro</I> and in cells derived from young and old human subjects. <I>Exp. Cell Res.</I>
<B>241, </B>404
&#150;413<!-- HIGHWIRE ID="1:4:280:65" --><!-- /HIGHWIRE --><P><A NAME="R66"><!-- null --></A>
<LI VALUE=66> Wadhwa, R., Takano, S., Robert, M., Yoshida, A., Nomura, H., Reddel, R. R., Mitsui, Y., and Kaul, S. C.
(1998) Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.
<I>J. Biol. Chem.</I>
<B>273, </B>29586
&#150;29591<!-- HIGHWIRE ID="1:4:280:66" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/45/29586" ><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><P><A NAME="R67"><!-- null --></A>
<LI VALUE=67> Kaula, S. C., Reddelb, R. R., Sugiharac, T., Mitsuia, Y., and Wadhwac, R.
(2000) Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2.
<I>FEBS Lett.</I>
<B>474, </B>159
&#150;164<!-- HIGHWIRE ID="1:4:280:67" --><A HREF="/cgi/external_ref?access_num=10.1016/S0014-5793(00)01594-5&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10838077&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P><A NAME="R68"><!-- null --></A>
<LI VALUE=68> Djelloul, S., Tarunina, M., Barnouin, K., Mackay, A., and Jat, P. S.
(2002) Differential protein expression, DNA binding and interaction with SV40 Large Tumour Antigen implicate the p63-family of proteins in senescence.
<I>Oncogene</I>
<B>21, </B>981
&#150;989<!-- HIGHWIRE ID="1:4:280:68" --><A HREF="/cgi/external_ref?access_num=10.1038/sj.onc.1205253&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=11850815&link_type=MED" >[Medline]</A><!-- /HIGHWIRE --><P></OL>


		
        
        
	
	
	
	
	





 






<BR CLEAR=ALL>




  <FONT FACE="">
  
  </FONT>
<BR CLEAR=ALL>
<BR CLEAR=ALL>



<A NAME="otherarticles"><!-- null --></A>

<P>
</body></html>